var title_f11_62_12256="MRA moyamoya";
var content_f11_62_12256=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F51947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F51947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance angiography (MRA) of a patient with moyamoya disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 183px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) There is severe narrowing of the distal part of the both carotid arteries (arrows). In addition, there is markedly reduced flow in the left middle cerebral artery and absence of both anterior cerebral arteries. B) Lateral projection MRA demonstrates severe narrowing of the distal internal carotid artery (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Nijasri Suwanwela, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12256=[""].join("\n");
var outline_f11_62_12256=null;
var title_f11_62_12257="Patient information: IgA nephropathy (The Basics)";
var content_f11_62_12257=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: IgA nephropathy (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/iga-nephropathy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H4618367\">",
"      <span class=\"h1\">",
"       What is IgA nephropathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;IgA nephropathy is a condition that happens when a protein called &ldquo;IgA&rdquo; builds up in the kidneys. IgA is a type of protein known as an &ldquo;antibody&rdquo; that helps the body fight infections. &ldquo;Nephropathy&rdquo; is the term doctors use to describe a problem with the kidneys.",
"     </p>",
"     <p>",
"      The kidneys filter blood and get rid of waste and excess salt and water in the body. IgA nephropathy damages the kidneys so they don&rsquo;t work well.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4618382\">",
"      <span class=\"h1\">",
"       What are the symptoms of IgA nephropathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people with the condition have no symptoms. But some people notice blood in their urine. This can happen just once or many times. People who have bloody urine usually get it after a cold or sore throat. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4618397\">",
"      <span class=\"h1\">",
"       Are there tests for IgA nephropathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse will ask about your symptoms and do an exam. Other tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Urine tests",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If these tests show you have kidney damage, your doctor might do a test called a &ldquo;kidney biopsy.&rdquo; For this test, he or she takes a small sample of tissue from your kidney to look at under the microscope. Usually, the doctor will get this sample by inserting a needle straight through the skin in the back and into the kidney.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4618412\">",
"      <span class=\"h1\">",
"       How is IgA nephropathy treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your blood and urine tests show that your kidneys are not damaged, you might not need treatment. But you should get blood and urine tests at least once a year to check how well your kidneys are working.",
"     </p>",
"     <p>",
"      If your blood or urine tests show signs of kidney damage, you might need to take medicines. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        ACE inhibitors or angiotensin receptor blockers &ndash; These medicines lower blood pressure and help protect the kidney from further damage.",
"       </li>",
"       <li>",
"        Statins &ndash; These medicines lower cholesterol and reduce the risk of heart attacks and strokes. That&rsquo;s important because people with kidney damage have a high risk of these problems. &nbsp;",
"       </li>",
"       <li>",
"        Steroids &ndash; These medicines help reduce inflammation in the kidneys. That&rsquo;s important because inflammation can cause scars to form in the kidneys.",
"       </li>",
"       <li>",
"        Fish oil &ndash; This fish oil is different from the fish oil you can get at a health food store. The fish oil you get from your doctor is prescription-strength fish oil. It might help reduce inflammation in the kidneys. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4618427\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have IgA nephropathy but do not have signs of kidney damage, your risk of having problems during pregnancy is only slightly higher than that of a woman without the condition. But if your kidneys show signs of damage, pregnancy can be dangerous for both you and your baby. The more damaged your kidneys are, the greater the risk of a problem.",
"     </p>",
"     <p>",
"      Also, common medicines to treat IgA nephropathy (ACE inhibitors and angiotensin receptor blockers) can cause birth defects. Because of this, women who might get pregnant should not take these medicines.",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?11/62/12257?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83746 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-77.94.48.4-442DE206A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12257=[""].join("\n");
var outline_f11_62_12257=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4618367\">",
"      What is IgA nephropathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4618382\">",
"      What are the symptoms of IgA nephropathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4618397\">",
"      Are there tests for IgA nephropathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4618412\">",
"      How is IgA nephropathy treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4618427\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_62_12258="Agenesis left lung";
var content_f11_62_12258=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Agenesis of left lung in newborn",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cardiomediastinal silhouette is shifted to the left and the right lung is hyperexpanded. Vertebral anomalies and scoliosis are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12258=[""].join("\n");
var outline_f11_62_12258=null;
var title_f11_62_12259="Pinching tourniquet";
var content_f11_62_12259=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85735&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85735&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pinching tourniquet",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12259=[""].join("\n");
var outline_f11_62_12259=null;
var title_f11_62_12260="T-PLL morphology";
var content_f11_62_12260=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    T cell prolymphocytic leukemia morphology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    PB morphology from a typical case of T-PLL showing medium-sized lymphoid cells with a regular nuclear outline, single nucleolus, and intense basophilic cytoplasm. An occasional cell shows a cytoplasmic protrusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     This research was originally published in Blood. Dearden C. How I treat prolymphocytic leukemia. Blood 2012; 120:538. Copyright &copy; 2012 American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12260=[""].join("\n");
var outline_f11_62_12260=null;
var title_f11_62_12261="Course and treatment of chronic bifascicular block";
var content_f11_62_12261=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Course and treatment of chronic bifascicular block",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12261/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12261/contributors\">",
"     William H Sauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12261/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12261/contributors\">",
"     Brian Olshansky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12261/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12261/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/62/12261/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bifascicular block most commonly refers to conduction disturbances below the atrioventricular (AV) node in which the right bundle branch and one of the two fascicles (anterior or posterior) of the left bundle branch are involved. Although this definition is used in the 2008 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/Heart",
"    </span>",
"    Rhythm Society",
"    <span class=\"nowrap\">",
"     (ACC/AHA/HRS)",
"    </span>",
"    guidelines for device-based therapy of cardiac rhythm abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/1\">",
"     1",
"    </a>",
"    ], some authors, including those of the guidelines on the management of syncope published by the European Society of Cardiology (ESC), include left bundle branch block (LBBB) in the definition of bifascicular block since LBBB implies block in both fascicles [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The term trifascicular block is also confusing since involvement of the right bundle branch and both fascicles of the left bundle branch would be manifested as complete heart block. Thus, trifascicular block is most often inaccurately applied to patients with bifascicular block and prolongation of the PR interval.",
"   </p>",
"   <p>",
"    A 2009",
"    <span class=\"nowrap\">",
"     AHA/ACCF/HRS",
"    </span>",
"    scientific statement on the standardization and interpretation of the electrocardiogram recommends against using the terms bifascicular and trifascicular block since these patterns do not have unique anatomic and pathologic substrates [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/3\">",
"     3",
"    </a>",
"    ]. Nevertheless, these terms are still widely used.",
"   </p>",
"   <p>",
"    Left bundle branch block and block involving only one fascicle, as with right bundle branch block (RBBB), left anterior fascicular block (LAFB), or left posterior fascicular block (LPFB), are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/54/39784?source=see_link\">",
"     \"Left bundle branch block\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10344?source=see_link\">",
"     \"Right bundle branch block\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/31/16886?source=see_link\">",
"     \"Left anterior fascicular block\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16420?source=see_link\">",
"     \"Left posterior fascicular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PROGRESSION TO COMPLETE HEART BLOCK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progression of chronic bifascicular block and bifascicular block with a prolonged PR interval to complete heart block is probably infrequent. One large study followed 554 such patients and noted that 1 percent per year progressed to complete heart block [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/4\">",
"     4",
"    </a>",
"    ]. As best as could be determined, most deaths were due to tachyarrhythmias rather than complete heart block. The Framingham study also suggested a low incidence of progression to advanced AV block [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other studies, however, have reported a higher incidence of progression. The rates ranged from 10 to 16 percent with RBBB and LAFB to as high as 21 to 75 percent with RBBB and left posterior fascicular block over a time period of one to six years in different studies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. One study evaluating the risk of progression from bifascicular block to complete heart block identified four risk factors: syncope, renal failure, an HV interval &gt;64 msec, and a QRS duration &gt;140 msec. In this study, the presence of all of these risk factors was correlated with a 95 percent rate of progression to complete heart block within one year [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognostic value of the PR or H-V interval, which may be prolonged in chronic bifascicular disease, is controversial. Initial studies noted a correlation between progression and these intervals, but later reports failed to support this relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. Prolongation of the H-V interval is also not a reliable predictor of sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/4,14-17\">",
"     4,14-17",
"    </a>",
"    ]. Nevertheless, some investigators believe that the symptomatic patient with bifascicular block and an H-V interval equal to or greater than 100 msec is a candidate for permanent pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. The development of infra-Hisian block during atrial pacing may be another indication for a pacemaker [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognostic significance of symptoms (particularly syncope) is also uncertain. Some investigators believe that advanced symptomatic multifascicular block is associated with a relatively high mortality, due in part to sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/4\">",
"     4",
"    </a>",
"    ]. However, most reports have not linked syncope with sudden death unless associated with transient or permanent complete heart block. Nevertheless, it has been suggested that otherwise unexplained syncope in the presence of bifascicular block is an indication for a permanent pacemaker [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. A randomized trial of empiric pacemaker implantation for patients with bifascicular block and syncope has been planned [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The significance and treatment of multifascicular block appearing during acute myocardial infarction is considered separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4282?source=see_link\">",
"     \"Conduction abnormalities after myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy of chronic bifascicular block begins by looking for and correcting reversible causes of impaired conduction such as myocardial ischemia and drugs that may slow conduction or prolong the refractory period of fascicular tissue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=see_link\">",
"     \"Etiology of atrioventricular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If no reversible causes are present, treatment involves the avoidance of medications that impair AV nodal conduction (when possible), and permanent pacemaker placement in selected patients. Detailed reviews of the indications for permanent pacemaker placement and of the modes of cardiac pacing are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H10#H10\">",
"     \"Indications for permanent cardiac pacing\", section on 'Acquired AV block'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Electrophysiology study",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrophysiology study is not usually performed in patients with Mobitz type 1 AV block, but may be considered to determine if patients who have otherwise unexplained syncope or presyncope are candidates for a pacemaker. In such patients, the following findings are possible indications for pacemaker placement:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AV block at the intra- or infra-His level",
"     </li>",
"     <li>",
"      Markedly prolonged conduction between the His bundle and the ventricle (HV interval &gt;100 msec)",
"     </li>",
"     <li>",
"      Pacing-induced AV block within or below the His bundle",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H14#H14\">",
"     \"Indications for permanent cardiac pacing\", section on 'Role of EP study'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pacemaker indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;We agree with the 2008 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/Heart",
"    </span>",
"    Rhythm Society",
"    <span class=\"nowrap\">",
"     (ACC/AHA/HRS)",
"    </span>",
"    device guideline recommendations for the use of permanent pacing in patients with chronic bifascicular block [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12261/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H5#H5\">",
"     \"Indications for permanent cardiac pacing\", section on 'Common indications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pacemaker placement may also be considered in patients with bifascicular block and unexplained syncope if other likely causes have been excluded. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link\">",
"     \"Evaluation of syncope in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Neuromuscular diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of neuromuscular diseases are associated with conduction abnormalities. These include myotonic muscular dystrophy, Kearns-Sayre syndrome, Erb's dystrophy (limb-girdle), and peroneal muscular atrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1351?source=see_link\">",
"     \"Inherited syndromes associated with cardiac disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These patients represent a special class and are treated more aggressively with pacemakers due to the potential for unpredictably rapid progression of conduction disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H23#H23\">",
"     \"Indications for permanent cardiac pacing\", section on 'Neuromuscular diseases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pacing mode",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important choice in most patients is whether to place a single or dual chamber pacemaker (",
"    <a class=\"graphic graphic_figure graphicRef71370 \" href=\"UTD.htm?28/21/29023\">",
"     figure 1",
"    </a>",
"    ). Single chamber, VVI pacing was most commonly used in the past, and is still used in the emergent setting for temporary pacing. Single chamber pacemakers are easier to implant and less expensive. The major disadvantage of VVI pacing is that the normal synchrony between atrial and ventricular contraction is lost, which is hemodynamically unfavorable and may result in \"pacemaker syndrome\", necessitating an upgrade to a dual chamber pacemaker. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In order to maintain physiologic pacing, dual chamber pacing is recommended. The advantages of physiologic pacing may be less significant in very elderly patients with AV block. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link&amp;anchor=H26#H26\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\", section on 'Potential advantages'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23343571\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bifascicular block most commonly refers to conduction disturbances below the atrioventricular (AV) node in which the right bundle branch and one of the two fascicles (anterior or posterior) of the left bundle branch are involved. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Progression of chronic bifascicular block and bifascicular block with a prolonged PR interval to complete heart block is probably infrequent. Risk factors for the progression from chronic bifascicular block to compete heart block appear to include syncope, renal failure, an HV interval &gt;64 msec, and a QRS duration &gt;140 msec. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Progression to complete heart block'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy of chronic bifascicular block begins by looking for and correcting reversible causes of impaired conduction such as myocardial ischemia and drugs that may slow conduction or prolong the refractory period of fascicular tissue. If no reversible causes are present, treatment involves the avoidance of medications that impair AV nodal conduction (when possible) and permanent pacemaker placement in selected patients. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link&amp;anchor=H10#H10\">",
"       \"Indications for permanent cardiac pacing\", section on 'Acquired AV block'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/1\">",
"      Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117:e350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/2\">",
"      Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009; 30:2631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/3\">",
"      Surawicz B, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 2009; 119:e235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/4\">",
"      McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of \"high-risk\" bundle-branch block: final report of a prospective study. N Engl J Med 1982; 307:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/5\">",
"      Schneider JF, Thomas HE, Kreger BE, et al. Newly acquired right bundle-branch block: The Framingham Study. Ann Intern Med 1980; 92:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/6\">",
"      Kulbertus HE. The magnitude of risk of developing complete heart block in patients with LAD-RBBB. Am Heart J 1973; 86:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/7\">",
"      Ranganathan N, Dhurandhar R, Phillips JH, Wigle ED. His Bundle electrogram in bundle-branch block. Circulation 1972; 45:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/8\">",
"      Scanlon PJ, Pryor R, Blount SG Jr. Right bundle-branch block associated with left superior or inferior intraventricular block. Clinical setting, prognosis, and relation to complete heart block. Circulation 1970; 42:1123.",
"     </a>",
"    </li>",
"    <li>",
"     DePadua FI, Pereirnha A, Lopes MG. Conduction defects. In: Electrocardiography: Theory and Practice in Health and Disease, MacFarlane P, Veitch Lawrie TD (Eds), Pergamon Press, New York 1989. p.459.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/10\">",
"      Mart&iacute;-Almor J, Cladellas M, Baz&aacute;n V, et al. [Novel predictors of progression of atrioventricular block in patients with chronic bifascicular block]. Rev Esp Cardiol 2010; 63:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/11\">",
"      Rosen KM, Rahimtoola SH, Chuquimia R, et al. Electrophysiological significance of first degree atrioventricular block with intraventricular conduction disturbance. Circulation 1971; 43:491.",
"     </a>",
"    </li>",
"    <li>",
"     Narula OS, Gann D, Samet P. Prognostic value of H-V intervals. In: His Bundle Electrocardiography and Clinical Electrophysiology, Narula OS, (Eds), FA Davis, Philadelphia 1975. p.437.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/13\">",
"      Denes P, Dhingra RC, Wu D, et al. H-V interval in patients with bifascicular block (right bundle branch block and left anterior hemiblock). Clinical, electrocardiographic and electrophysiologic correlations. Am J Cardiol 1975; 35:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/14\">",
"      Dhingra RC, Denes P, Wu D, et al. Prospective observations in patients with chronic bundle branch block and marked H-V prolongation. Circulation 1976; 53:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/15\">",
"      Scheinman MM, Peters RW, Modin G, et al. Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation 1977; 56:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/16\">",
"      McAnulty JH, Kauffman S, Murphy E, et al. Survival in patients with intraventricular conduction defects. Arch Intern Med 1978; 138:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/17\">",
"      Scheinman MM, Peters RW, Suav&eacute; MJ, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982; 50:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/18\">",
"      Morady F, Higgins J, Peters RW, et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol 1984; 54:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/19\">",
"      Click RL, Gersh BJ, Sugrue DD, et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol 1987; 59:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/20\">",
"      Dhingra RC, Wyndham C, Bauernfeind R, et al. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation 1979; 60:1455.",
"     </a>",
"    </li>",
"    <li>",
"     Lie KI, Wellens HJJ, Schuilenburg RM. Bundle branch block and acute myocardial infarction. In: The Conduction System of the Heart: Structure, Function and Clinical Implications, Wellens HJJ, Lie KI, Janse MD (Eds), Lea &amp; Febiger, Philadelphia 1976. p.662.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/22\">",
"      Kulbertus H, Collignon P. Association of right bundle-branch block with left superior or inferior intraventricular block. Its relation to complete heart block and Adams-Stokes syndrome. Br Heart J 1969; 31:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12261/abstract/23\">",
"      Krahn AD, Morillo CA, Kus T, et al. Empiric pacemaker compared with a monitoring strategy in patients with syncope and bifascicular conduction block--rationale and design of the Syncope: Pacing or Recording in ThE Later Years (SPRITELY) study. Europace 2012.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1063 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-E927C15C8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12261=[""].join("\n");
var outline_f11_62_12261=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23343571\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PROGRESSION TO COMPLETE HEART BLOCK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Electrophysiology study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pacemaker indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Neuromuscular diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pacing mode",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23343571\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1063\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1063|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/21/29023\" title=\"figure 1\">",
"      Pacemaker algorithm AV block",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/11/4282?source=related_link\">",
"      Conduction abnormalities after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=related_link\">",
"      Etiology of atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=related_link\">",
"      Evaluation of syncope in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=related_link\">",
"      Indications for permanent cardiac pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1351?source=related_link\">",
"      Inherited syndromes associated with cardiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/31/16886?source=related_link\">",
"      Left anterior fascicular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/54/39784?source=related_link\">",
"      Left bundle branch block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16420?source=related_link\">",
"      Left posterior fascicular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=related_link\">",
"      Modes of cardiac pacing: Nomenclature and selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10344?source=related_link\">",
"      Right bundle branch block",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_62_12262="Tissue Doppler";
var content_f11_62_12262=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Example of tissue Doppler recordings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 596px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Sherif F Nagueh.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12262=[""].join("\n");
var outline_f11_62_12262=null;
var title_f11_62_12263="Radiofrequency treatment for gastroesophageal reflux disease (the Stretta procedure)";
var content_f11_62_12263=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiofrequency treatment for gastroesophageal reflux disease (the Stretta&reg; procedure)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12263/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12263/contributors\">",
"     George Triadafilopoulos, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12263/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12263/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12263/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12263/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/62/12263/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard therapy for gastroesophageal reflux disease (GERD) involves behavioral modifications and treatment with medications that reduce acid production or improve esophageal motility. Open or laparoscopic Nissen fundoplication may be chosen for those patients who do not wish to remain on an antisecretory medication, have an inadequate response to antisecretory medication, have a large hiatal hernia, or have persistence of esophagitis on medication. Esophagitis and GERD symptoms are improved or resolved after fundoplication in 76 to 98 percent of patients, while esophageal acid exposure time is normalized in approximately 90 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42905?source=see_link\">",
"     \"Surgical management of gastroesophageal reflux in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Minimally invasive alternatives to standard antireflux surgery have been developed, and include [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plication of tissues in the lower esophageal region with sutures, transmural fasteners, or staples that are placed during endoscopy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/5/25688?source=see_link\">",
"       \"Endoscopic therapy for gastroesophageal reflux disease: Sewing and full-thickness plication techniques\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Injection of a biopolymer into the lower esophageal sphincter (Enteryx, Boston Scientific). However, the procedure has been associated with severe complications, including pneumomediastinum, embolization of the polymer leading to renal failure, esophageal stenosis, and a death due to intra-aortic injection of the polymer. Because of these complications it was recalled in 2005.",
"     </li>",
"     <li>",
"      Application of controlled radiofrequency (RF) energy to the lower esophageal sphincter region (Stretta procedure). The Stretta system was approved by the Food and Drug Administration in the United States in 2000. It was originally produced by Curon Medical, Inc., but the company filed for bankruptcy in 2006. In 2008 Mederi Therapeutics, Inc. (Greenwich, CT) acquired Curon Medical&rsquo;s assets, and the Stretta system became commercially available again in 2010.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review will provide an overview of radiofrequency treatment for GERD (Stretta procedure). Medical, surgical, and alternative endoscopic treatments for GERD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/53/42840?source=see_link\">",
"     \"Medical management of gastroesophageal reflux disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42905?source=see_link\">",
"     \"Surgical management of gastroesophageal reflux in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/5/25688?source=see_link\">",
"     \"Endoscopic therapy for gastroesophageal reflux disease: Sewing and full-thickness plication techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RATIONALE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency (RF) energy induces collagen contraction and has been shown to have therapeutic benefits in patients with cardiac arrhythmias, joint laxity, benign prostatic hyperplasia, and sleep-disordered breathing. Although the precise mechanisms of benefit in gastroesophageal reflux disease (GERD) are unclear, RF treatment appears to reduce postprandial transient lower esophageal sphincter relaxations and decrease compliance of the gastroesophageal junction, may decrease esophageal acid sensitivity, and may improve gastroparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13928?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathophysiology of reflux esophagitis\", section on 'Transient lower esophageal sphincter relaxations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One theory is that RF treatment improves symptoms of GERD through radiofrequency ablation of sensory neurons of the distal esophagus, leading to hyposensitization without an effect on pH. In a study of 13 patients undergoing pH monitoring and Bernstein acid perfusion testing, esophageal acid sensitivity was decreased six months after the Stretta procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/3\">",
"     3",
"    </a>",
"    ]. However, this hypothesis was not supported in a preliminary report of 118 patients examining the relationship between symptom improvement (GERD-health-related quality of life [HRQL] and heartburn scores, general satisfaction, daily proton pump inhibitor [PPI] use) and intraesophageal acid exposure (percent proximal and distal esophageal time with pH &lt;4.0) six months after Stretta [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/5\">",
"     5",
"    </a>",
"    ]. Responders to Stretta had significant improvements in both proximal and distal acid exposure times. In contrast, nonresponders had either no improvement or less improvement in proximal and distal acid exposure times. Changes in GERD-HRQL and heartburn severity positively correlated with changes in acid exposure.",
"   </p>",
"   <p>",
"    In a sham-controlled study, Stretta improved GERD symptoms and decreased GEJ compliance three months after the initial Stretta procedure. In this trial, the administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    , an esophageal smooth muscle relaxant, normalized GEJ compliance again to pre-Stretta levels, arguing against GEJ fibrosis as the underlying mechanism. Decreased GEJ compliance, which reflects altered LES neuromuscular function, may contribute to the symptomatic benefit of the Stretta procedure by decreasing refluxate volume. The study was limited because it did not include impedance monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Delayed gastric emptying (gastroparesis) may be associated with severe reflux. In a single practice cohort study, Stretta was shown to correct gastroparesis and significantly improve symptoms. Of 31 patients treated, 23 patients (74 percent) normalized gastric emptying, while all patients had significant improvements in GERD-HRQL at one-year symptom assessment. The mechanism of action remains unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2748502\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ideal candidates for radiofrequency (RF) treatment are those who:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Suffer from frequent heartburn, regurgitation, or both",
"     </li>",
"     <li>",
"      Have adequate esophageal peristalsis",
"     </li>",
"     <li>",
"      Have a 24-hour pH study demonstrating pathologic acid reflux (total acid exposure time greater than 4 percent, or a DeMeester composite score &gt;14.7)",
"     </li>",
"     <li>",
"      Have nonerosive reflux disease, have grade I or II esophagitis by Savary-Miller criteria, or have higher grades of esophagitis healed by drug therapy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=see_link&amp;anchor=H575215834#H575215834\">",
"       \"Clinical manifestations and diagnosis of gastroesophageal reflux in adults\", section on 'Savary-Miller classification'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Have unsatisfactory control of GERD with properly escalated proton pump inhibitor therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, patients may be offered RF therapy if they do not wish to be on long-term medical treatment for GERD.",
"   </p>",
"   <p>",
"    Patients are not considered as good candidates for RF therapy if they:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Have a more than 2-cm long hiatal hernia detected endoscopically or radiographically",
"     </li>",
"     <li>",
"      Have significant dysphagia",
"     </li>",
"     <li>",
"      Have grade III or IV esophagitis by Savary-Miller criteria that has not been healed by drug therapy",
"     </li>",
"     <li>",
"      Have inadequate esophageal peristalsis and incomplete lower esophageal sphincter relaxation in response to a swallow",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The four-channel radiofrequency (RF) generator and catheter system delivers pure sine-wave energy (465 kHz, 2 to 5 watts per channel, 80 volts maximum at 100 to 800 ohms). Each needle tip incorporates a thermocouple that automatically modulates power output to maintain a desired target (muscle) tissue temperature. Maintaining lesion temperatures below 100&ordm;C minimizes the collateral tissue damage due to vaporization and high impedance values. Temperature is similarly monitored with a thermocouple at each needle base, and power delivery ceases if the mucosal temperature exceeds 47&ordm;C.",
"   </p>",
"   <p>",
"    Patients are prepared in a manner similar to that for standard esophagogastroduodenoscopy (EGD). Intravenous access is obtained, and heart rate, blood pressure, and oxygen saturation are monitored. Patients typically require high doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    (5 to 7 mg) and either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    (100 to 150 &micro;g) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    (100 to 125 mg) during treatment. There is mild discomfort due to catheter passage in 25 percent of cases; mild-to-moderate discomfort is also experienced with RF delivery in 50 to 70 percent of cases. In those cases, additional medication is generally provided. Alternatively, intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    may be used. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24936?source=see_link\">",
"     \"Overview of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A standard EGD is then performed, and the distance from the incisors to the squamocolumnar junction (z-line) is measured. The endoscope is removed, and the RF catheter is passed transorally and positioned 2 cm above the z-line according to the distance measured during EGD (",
"    <a class=\"graphic graphic_figure graphicRef52786 \" href=\"UTD.htm?22/19/22833\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef81200 \" href=\"UTD.htm?21/20/21825\">",
"     figure 2",
"    </a>",
"    ). The four needle electrodes are deployed to a preset length of 5.5 mm and RF delivery commenced. Each electrode delivers RF energy for 90 seconds to achieve a target temperature of 85&ordm;C. Additional lesion sets are created by rotating and changing the linear position of the catheter so as to create several rings of lesions 2 cm above and below cardia. The catheter is then removed and the EGD repeated. Currently, patients receive 56 lesions placed over a period of 35 minutes (",
"    <a class=\"graphic graphic_figure graphicRef69012 \" href=\"UTD.htm?39/28/40384\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef82292 \" href=\"UTD.htm?9/60/10177\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have examined the efficacy of radiofrequency (RF) treatment for gastroesophageal reflux disease (GERD). Overall, 55 to 83 percent patients have reported satisfactory symptom control or cessation of proton pump inhibitor (PPI) use in studies with average follow-up periods of 12 to 33 months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/7-11\">",
"     7-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Representative trials have demonstrated the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One randomized trial included 64 patients who were assigned to RF treatment or a sham procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/12\">",
"       12",
"      </a>",
"      ]. At six months, those who had undergone the RF procedure were significantly more likely to experience a &gt;50 percent improvement in heartburn-related quality-of-life (HRQL) scores compared with sham treated patients (61 versus 30 percent) and were more likely to be without daily heartburn symptoms (61 versus 33 percent). The groups had similar median acid exposure times, though acid exposure time was significantly improved when responders (&gt;30 percent decrease in heartburn score) were compared with non-responders.",
"     </li>",
"     <li>",
"      In a second trial, 36 patients were assigned to a single session RF procedure (12 patients), a sham procedure (12 patients), or RF treatment with a repeat RF treatment if GERD health-related quality of life (HRQL) was not 75 percent improved after four months (12 patients, 10 of whom underwent a second RF procedure) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/13\">",
"       13",
"      </a>",
"      ]. Patients who underwent RF procedures had greater improvements in HRQL scores at 12 months than patients who underwent sham therapy, and patients in the double RF group showed a greater improvement than patients who underwent a single treatment. In the single RF group two patients (17 percent) normalized their HRQL scores, in the double RF group seven patients (58 percent) normalized, and in the sham group no patients normalized. Similar findings were noted with regard to the number of patients no longer requiring GERD medications.",
"     </li>",
"     <li>",
"      A nonrandomized, prospective, multicenter study included 118 patients who all received RF treatment for GERD [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/7,14\">",
"       7,14",
"      </a>",
"      ]. Follow-up information was available for 94 patients (80 percent) at 12 months. Significant improvements were observed in the median heartburn, GERD, and satisfaction scores, and on the mental and physical components of the Medical Outcomes Study Short Form-36 (SF-36). The proportion of patients requiring proton pump inhibitors fell from 88 to 30 percent. Esophageal acid exposure improved significantly (from 10 to 6 percent). The authors noted that the degree of improvement in quality of life was similar to the improvement described following fundoplication [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/15\">",
"       15",
"      </a>",
"      ]. The 24 patients who did not return their questionnaires were counted as treatment failures in the analysis. However, all of the patients were contacted and none had experienced complications.",
"      <br/>",
"      <br/>",
"      Eighteen of the patients agreed to undergo additional testing that included esophageal manometry [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/16\">",
"       16",
"      </a>",
"      ]. No significant change in any esophageal motility parameter was observed, although there was a trend toward a reduction in the number of transient lower esophageal sphincter relaxations.",
"     </li>",
"     <li>",
"      In another open trial of 90 patients with non-erosive or mildly erosive disease, the onset of GERD symptom relief after Stretta was less than two months in 70.0 percent or two to six months in 16.7 percent. The mean GERD-HRQL score was 25.6 (baseline), 7.3 (six months, P &lt;0.01), and 8.1 (12 months, P &lt;0.01). The mean heartburn score was 3.3 (baseline), and 1.2 (12 months, P &lt;0.05). The percentage of patients with satisfactory GERD control improved from 31.1 percent at baseline to 86.7 percent after treatment, and patient satisfaction improved from 1.4 at baseline to 4.0 at 12 months (P &lt;0.01). Medication usage decreased significantly from 100 percent of patients on PPI therapy at baseline to 76.7 percent of patients showing elimination of medications or only as-needed use of",
"      <span class=\"nowrap\">",
"       antacids/H2-receptor",
"      </span>",
"      antagonists at 12 months [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455508854\">",
"    <span class=\"h2\">",
"     Long-term studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;An Italian study reported 48-month follow-up data for 56 out of 69 patients who were treated with the Stretta procedure. RF treatment significantly improved heartburn scores, GERD-specific quality of life scores, and general quality of life scores at 24 and 48 months in 52 out of 56 patients (92.8 percent). At each time point, both mean heartburn and GERD HRQL scores decreased (P = 0.001 and P = 0.003, respectively), and both mental SF-36 and physical SF-36 scores improved (P = 0.001 and 0.05, respectively). At 48 months, 41 out of 56 patients (72.3 percent) were completely off PPIs. Morbidity was minimal, except for one patient who developed transient gastroparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/18\">",
"     18",
"    </a>",
"    ].",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2748073\">",
"    <span class=\"h2\">",
"     Comparison with surgical treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have compared RF treatment with fundoplication for the treatment of GERD with variable results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One group stratified patients to either endoscopic therapy or laparoscopic fundoplication [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/8,19,20\">",
"       8,19,20",
"      </a>",
"      ]. Patients were offered RF treatment if they did not have a hiatal hernia greater than 2 cm, had a lower esophageal pressure of at least 8 mmHg, and did not have Barrett&rsquo;s esophagus. At six months, the quality of life scores were similar in both groups and both groups were satisfied with their procedures (89 percent of RF treated patients and 96 percent of fundoplication patients). Fifty-eight percent of RF patients and 97 percent of fundoplication patients were off of proton pump inhibitors (PPI) and an additional 31 percent of RF patients had reduced their PPI dose significantly. The mean hospital cost for RF treatment was $1808, whereas it was $5715 for fundoplication.",
"     </li>",
"     <li>",
"      In a non-randomized cohort of 32 patients referred to a surgical practice who underwent RF treatment with an average follow-up of 53 months, 19 patients (59 percent) subsequently required anti-reflux surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/21\">",
"       21",
"      </a>",
"      ]. Those not undergoing surgery showed a significant improvement in their GERD satisfaction scores from 3.1 to 1.5, but had significantly lower pre-procedure heartburn scores (2.4) than those who proceeded to surgery. The Stretta procedure was effective in reducing symptoms in 40 percent of patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2748837\">",
"    <span class=\"h2\">",
"     Use in obese patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obese patients (BMI &gt;30) are often not ideal candidates for fundoplication and are at increased risk of failure after antireflux surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. RF treatment has been effective in improving GERD in selected obese patients (BMI &gt;30) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/24\">",
"     24",
"    </a>",
"    ]. Following RF treatment, 6 of 10 patients reported having no or very mild symptoms. Since obesity is a preoperative predictor of failure after antireflux surgery, Stretta can provide a safe means of improving GERD symptoms for some obese patients with GERD refractory to medical therapy. In a retrospective study of 12 consecutive obese patients (mean BMI 38.6) with GERD undergoing Stretta with a mean follow-up of 1.5 years, there were fewer patients on PPI medications after the procedure than before (45 versus 81 percent, p = 0.1) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These data suggest that RF treatment may provide a safe means of improving GERD symptoms for some obese patients with GERD refractory to medical therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2748038\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Post-marketing experience has supported a generally good safety profile. However, serious complications have been described, including esophageal perforation in four patients and two deaths due to aspiration pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/25\">",
"     25",
"    </a>",
"    ]. The perforations were attributed to either poor patient selection or operator error.",
"   </p>",
"   <p>",
"    In the study of 118 patients described above, 10 complications were observed (9 percent), none of which required therapeutic intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/7\">",
"     7",
"    </a>",
"    ]. These included fever (two patients), superficial mucosal injury (three patients), chest pain requiring opioid analgesics (two patients), transient dysphagia for solids (one patient), sedation-related hypotension (one patient), and submental swelling related to topical analgesia allergy (one patient).",
"   </p>",
"   <p>",
"    In a literature review of endoscopic therapies for gastroesophageal reflux disease, the most common complications were transient epigastric pain (66 percent), chest pain (15 percent), esophageal ulceration (4 percent), and dysphagia or odynophagia (3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2748301\">",
"    <span class=\"h1\">",
"     COST-EFFECTIVENESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term follow-up with radiofrequency (RF) treatment in a large group of patients with gastroesophageal reflux disease (GERD) is emerging. The precise role of this endoscopic therapy for GERD will require further study and long-term follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Nevertheless, among the available endoscopic procedures, RF treatment has favorable characteristics in terms of ease of use, efficacy, and cost [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To evaluate the cost-effectiveness of RF treatment compared with competing strategies in the long-term management of GERD in Canada, a Markov model was designed to estimate health outcomes and costs from a Ministry of Health perspective over five years [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12263/abstract/31\">",
"     31",
"    </a>",
"    ]. Strategies included the use of a daily proton pump inhibitor (PPI), laparoscopic Nissen fundoplication (LNF), and RF treatment using the Stretta procedure. If symptom-free months were used as the measure of effectiveness, PPIs dominated both Stretta and LNF strategies. If quality of life years were used, PPIs still presented the lowest cost, but LNF had the highest efficacy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radiofrequency (RF) treatment of the gastroesophageal junction is an endoscopic management option for some patients with for gastroesophageal reflux disease (GERD).",
"     </li>",
"     <li>",
"      Although the precise mechanisms of benefit in GERD are unclear, RF treatment appears to reduce postprandial transient lower esophageal sphincter relaxations and decrease compliance of the gastroesophageal junction, may decrease esophageal acid sensitivity, and may improve gastroparesis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Rationale'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ideal candidates for RF treatment are those with daily heartburn or regurgitation who exhibit inadequate or partial symptom response to antisecretory therapy (typically proton pump inhibitors). This treatment can also be considered for those who wish to discontinue the long-term use of drugs, for those who cannot tolerate drug therapy, and for those patients considering fundoplication. However, RF treatment has only been evaluated in patients without large (&gt;3 cm) hiatal hernias or Barrett's metaplasia and who had normal esophageal peristalsis and lower esophageal sphincter relaxation. (See",
"      <a class=\"local\" href=\"#H2748502\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Overall, 55 to 83 percent patients treated with RF procedures have reported satisfactory symptom control or cessation of proton pump inhibitor use in studies with average follow-up periods of 12 to 33 months. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complications associated with RF treatment include transient epigastric pain (66 percent), chest pain (15 percent), esophageal ulceration (4 percent), and dysphagia or odynophagia (3 percent). However, rare serious complications have also been described including esophageal perforation and death due to aspiration pneumonia. (See",
"      <a class=\"local\" href=\"#H2748038\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/1\">",
"      Utley DS, Kim M, Vierra MA, Triadafilopoulos G. Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a porcine model. Gastrointest Endosc 2000; 52:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/2\">",
"      Tam WC, Schoeman MN, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut 2003; 52:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/3\">",
"      Arts J, Sifrim D, Rutgeerts P, et al. Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease. Dig Dis Sci 2007; 52:2170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/4\">",
"      Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol 2012; 107:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/5\">",
"      Triadafilopoulos G. Changes in GERD symptom scores correlate with improvement in esophageal acid exposure after the Stretta procedure. Surg Endosc 2004; 18:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/6\">",
"      Noar MD, Noar E. Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction. Surg Endosc 2008; 22:2440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/7\">",
"      Triadafilopoulos G, DiBaise JK, Nostrant TT, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 2002; 55:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/8\">",
"      Richards WO, Houston HL, Torquati A, et al. Paradigm shift in the management of gastroesophageal reflux disease. Ann Surg 2003; 237:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/9\">",
"      Wolfsen HC, Richards WO. The Stretta procedure for the treatment of GERD: a registry of 558 patients. J Laparoendosc Adv Surg Tech A 2002; 12:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/10\">",
"      Torquati A, Houston HL, Kaiser J, et al. Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease. Surg Endosc 2004; 18:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/11\">",
"      White B, Jeansonne LO, Cook M, et al. Use of endoluminal antireflux therapies for obese patients with GERD. Obes Surg 2009; 19:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/12\">",
"      Corley DA, Katz P, Wo JM, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 2003; 125:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/13\">",
"      Aziz AM, El-Khayat HR, Sadek A, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc 2010; 24:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/14\">",
"      Triadafilopoulos G, Dibaise JK, Nostrant TT, et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc 2001; 53:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/15\">",
"      Velanovich V. Comparison of symptomatic and quality of life outcomes of laparoscopic versus open antireflux surgery. Surgery 1999; 126:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/16\">",
"      DiBaise JK, Brand RE, Quigley EM. Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action. Am J Gastroenterol 2002; 97:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/17\">",
"      Liu HF, Zhang JG, Li J, et al. Improvement of clinical parameters in patients with gastroesophageal reflux disease after radiofrequency energy delivery. World J Gastroenterol 2011; 17:4429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/18\">",
"      Dughera L, Navino M, Cassolino P, et al. Long-Term Results of Radiofrequency Energy Delivery for the Treatment of GERD: Results of a Prospective 48-Month Study. Diagn Ther Endosc 2011; 2011:507157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/19\">",
"      Richards WO, Scholz S, Khaitan L, et al. Initial experience with the stretta procedure for the treatment of gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A 2001; 11:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/20\">",
"      Houston H, Khaitan L, Holzman M, Richards WO. First year experience of patients undergoing the Stretta procedure. Surg Endosc 2003; 17:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/21\">",
"      Dundon JM, Davis SS, Hazey JW, et al. Radiofrequency energy delivery to the lower esophageal sphincter (Stretta procedure) does not provide long-term symptom control. Surg Innov 2008; 15:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/22\">",
"      Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001; 15:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/23\">",
"      Morgenthal CB, Lin E, Shane MD, et al. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 2007; 21:1978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/24\">",
"      Go MR, Dundon JM, Karlowicz DJ, et al. Delivery of radiofrequency energy to the lower esophageal sphincter improves symptoms of gastroesophageal reflux. Surgery 2004; 136:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/25\">",
"      Gersin K, Fanelli R. The Stretta procedure: Review of catheter and technique evolution, efficacy and complications 2 years after introduction. Surg Endosc 2002; 16 (Suppl 1):PF199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/26\">",
"      Chen D, Barber C, McLoughlin P, et al. Systematic review of endoscopic treatments for gastro-oesophageal reflux disease. Br J Surg 2009; 96:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/27\">",
"      Kahrilas PJ. Radiofrequency therapy of the lower esophageal sphincter for treatment of GERD. Gastrointest Endosc 2003; 57:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/28\">",
"      Roy-Shapira A, Stein HJ, Scwartz D, et al. Endoluminal methods of treating gastroesophageal reflux disease. Dis Esophagus 2002; 15:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/29\">",
"      Galmiche JP, Bruley des Varannes S. Endoluminal therapies for gastro-oesophageal reflux disease. Lancet 2003; 361:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/30\">",
"      Lutfi RE, Torquati A, Richards WO. Endoscopic treatment modalities for gastroesophageal reflux disease. Surg Endosc 2004; 18:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12263/abstract/31\">",
"      Comay D, Adam V, da Silveira EB, et al. The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis. Can J Gastroenterol 2008; 22:552.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2254 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-115.25.216.6-C9C7C661E2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12263=[""].join("\n");
var outline_f11_62_12263=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RATIONALE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2748502\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H455508854\">",
"      Long-term studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2748073\">",
"      Comparison with surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2748837\">",
"      Use in obese patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2748038\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2748301\">",
"      COST-EFFECTIVENESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2254\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2254|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/19/22833\" title=\"figure 1\">",
"      Position of the RF catheter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/20/21825\" title=\"figure 2\">",
"      RF energy delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/28/40384\" title=\"figure 3\">",
"      GEJ after therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/60/10177\" title=\"figure 4\">",
"      Six months after RF treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/5/25688?source=related_link\">",
"      Endoscopic therapy for gastroesophageal reflux disease: Sewing and full-thickness plication techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/53/42840?source=related_link\">",
"      Medical management of gastroesophageal reflux disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24936?source=related_link\">",
"      Overview of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13928?source=related_link\">",
"      Pathophysiology of reflux esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42905?source=related_link\">",
"      Surgical management of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_62_12264="Clostridial myonecrosis";
var content_f11_62_12264=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clostridial myonecrosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12264/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12264/contributors\">",
"     Dennis L Stevens, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12264/contributors\">",
"     Amy Bryant, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12264/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12264/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12264/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12264/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/62/12264/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 31, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clostridial myonecrosis (gas gangrene) is a life-threatening muscle infection that develops either contiguously from an area of trauma or hematogenously from the gastrointestinal tract with muscle seeding. Early recognition and aggressive treatment are essential.",
"   </p>",
"   <p>",
"    Most infections resulting in myonecrosis are due to Clostridium species (gas gangrene) or group A streptococcus (Streptococcus pyogenes). The clinical features and therapy of necrotizing muscle infections due to Clostridium species will be reviewed here. Streptococcal necrotizing myositis and clostridial and streptococcal infections that primarily involve the fascia and skin are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=see_link\">",
"     \"Necrotizing soft tissue infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several other clinical entities can be confused with myonecrosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Necrotizing infections including necrotizing fasciitis due to group A streptococcus or Vibrio vulnificus. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=see_link\">",
"       \"Necrotizing soft tissue infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44710?source=see_link\">",
"       \"Vibrio vulnificus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Staphylococcus aureus can cause pyomyositis (primary muscle abscess in the absence of an apparent site of infection). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32950?source=see_link\">",
"       \"Pyomyositis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Viral infection such as acute influenza type A can also produce skeletal muscle injury resulting in rhabdomyolysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SPECTRUM OF CLOSTRIDIAL INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clostridium species are widespread in nature due to their ability to form endospores. They are commonly found in soil and marine sediments, as well as human and animal intestinal tracts. There are three major categories of clostridial soft tissue infections: wound contamination, anaerobic cellulitis, and myonecrosis (gas gangrene) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Contamination of open wounds with soil containing clostridial spores or vegetative organisms may occur frequently, although wound contamination with clostridial species in the absence of devitalized tissue does not necessarily lead to infection. In one study, for example, 30 to 80 percent of open traumatic wounds were contaminated with clostridial species [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Anaerobic cellulitis occurs in the setting of modest quantities of devitalized tissue that support the growth of C. perfringens or other clostridial strains. Gas is produced locally and extends along fascial planes, although bacteremia and invasion of healthy tissue (including muscle) does not occur. Mortality is low in the setting of appropriate management including prompt removal of the devitalized tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Myonecrosis (clostridial gas gangrene) may be distinguished from the above infections by the progressive invasion and destruction of healthy muscle tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/2\">",
"       2",
"      </a>",
"      ]. There are two major presentations of clostridial gas gangrene: traumatic and spontaneous. Traumatic gas gangrene is most commonly caused by C. perfringens; spontaneous gangrene is most commonly caused by C. septicum. These are discussed in the following sections (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Traumatic gas gangrene'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H12\">",
"       'Spontaneous gas gangrene'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TRAUMATIC GAS GANGRENE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic wounds with vascular compromise (particularly deep penetrating injuries such as knife wounds, gunshot wounds, and crush injuries) create an anaerobic environment that is ideal for proliferation of clostridia. Traumatic injury accounts for about 70 percent of gas gangrene cases, and about 80 percent of these are caused by C. perfringens [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1\">",
"     1",
"    </a>",
"    ]. Other pathogens include C. septicum, C. novyi, C. histolyticum, C. bifermentans, C. tertium, and C. fallax.",
"   </p>",
"   <p>",
"    Other conditions associated with traumatic gas gangrene include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bowel and biliary tract surgery",
"     </li>",
"     <li>",
"      Abortion",
"     </li>",
"     <li>",
"      Retained placenta",
"     </li>",
"     <li>",
"      Prolonged rupture of the membranes",
"     </li>",
"     <li>",
"      Intrauterine fetal demise",
"     </li>",
"     <li>",
"      Intramuscular injection",
"     </li>",
"     <li>",
"      Black tar heroin injection (skin popping) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recurrent gas gangrene due to C. perfringens has been described in individuals with minor trauma at sites of previous gas gangrene [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/4\">",
"     4",
"    </a>",
"    ]. Such cases are likely attributable to the germination of residual C. perfringens spores, which can remain quiescent in the tissues for decades.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     C. perfringens toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many extracellular toxins are produced by C. perfringens; of these, only alpha and theta toxins have been implicated in pathogenesis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alpha toxin is a hemolytic toxin with both phospholipase C (PLC) and sphingomyelinase activities. Two independent studies have identified alpha toxin (also called PLC) as an essential toxin in disease. First, genetic interruption of the alpha toxin gene in C. perfringens rendered the organism avirulent in a mouse myonecrosis model [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1\">",
"       1",
"      </a>",
"      ]. Complementation of the chromosomal mutation with a recombinant plasmid carrying a wild-type gene fully restored ability to cause disease. Second, vaccination with the C-terminal domain of alpha toxin (amino acids 247 to 370) protected mice from experimental C. perfringens infection in part by improving tissue perfusion and restoring the tissue inflammatory response [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/5,6\">",
"       5,6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Theta toxin (also known as perfringolysin O, PFO) is a member of the cholesterol dependent cytolysin family (CDC) that includes streptolysin O, pneumolysin, listeriolysin, septicolysin and others [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/7\">",
"       7",
"      </a>",
"      ]. These pore-forming toxins contain a conserved amino acid motif. Theta toxin appears to contribute to pathogenesis by its affects on cells of the vascular and immune systems [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/8-10\">",
"       8-10",
"      </a>",
"      ]. However, theta toxin is not essential in causing mortality since isogenic mutant strains lacking an intact theta toxin structural gene (pfoA) remained lethal in the mouse myonecrosis model [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trauma introduces organisms (vegetative or spore forms) directly into deep tissue. If trauma compromises the blood supply, an anaerobic environment forms with low oxidation-reduction potential and acidic pH, which is optimal for growth of clostridial organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Necrosis progresses within 24 to 36 hours of the traumatic injury.",
"   </p>",
"   <p>",
"    In gas gangrene, muscle necrosis is severe, and polymorphonuclear leukocytes (PMNs) are notably absent from infected tissues. This is in striking contrast to soft tissue infections caused by organisms such as S. aureus, in which significant influx of PMNs localizes the infection without adjacent tissue or vascular destruction. In the setting of clostridial infection, PMNs arriving at the site of infection adhere to and accumulate along the endothelium of capillaries, small arterioles, and postcapillary venules, but do not cross the vascular endothelium into infected tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Molecular and animal studies have shown that alpha toxin is largely responsible for both the widespread tissue necrosis and the characteristic absence of tissue inflammatory response. Alpha toxin potently stimulates platelet aggregation and upregulates adherence molecules on PMN and endothelial cells. Experimental intramuscular alpha toxin injection causes a rapid, irreversible decline in muscle blood flow and concomitant ischemic necrosis of tissue due to the formation of occlusive intravascular aggregates composed of activated platelets, leukocytes, and fibrin. The perfusion deficits expand the anaerobic environment and contribute to the rapidly advancing margins of tissue destruction characteristic of clostridial gas gangrene. In addition, large heterotypic aggregates of activated platelets and PMN reduce the ability of PMNs to cross the endothelial cell barrier into infected tissues. These processes appear to be dependent on alpha toxin-induced activation of the platelet fibrinogen receptor, glycoprotein",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/13,14\">",
"     13,14",
"    </a>",
"    ], suggesting that platelet glycoprotein inhibitors (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/24/32135?source=see_link\">",
"     eptifibatide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/15/6392?source=see_link\">",
"     abciximab",
"    </a>",
"    ) may be therapeutic for maintaining tissue blood flow.",
"   </p>",
"   <p>",
"    Shock associated with gas gangrene may be attributable to both direct and indirect effects of alpha and theta toxins. Alpha toxin directly suppresses myocardial contractility and may contribute to profound hypotension via a sudden reduction in cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. In experimental models, theta toxin causes markedly reduced systemic vascular resistance combined with a markedly increased cardiac output (ie, \"warm shock\") [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. This likely occurs via induction of endogenous mediators such as prostacyclin, platelet activating factor, and other lipid autocoids that cause vasodilation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with gram-negative sepsis compensate for hypotension by markedly increasing cardiac output. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5449?source=see_link\">",
"     \"Pathophysiology of sepsis\"",
"    </a>",
"    .) However, this adaptive mechanism may not be possible in the setting of shock due to C. perfringens given the negative inotropic effect of alpha toxin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/15\">",
"     15",
"    </a>",
"    ]. The roles of other endogenous mediators such as cytokines (eg, tumor necrosis factor, interleukin-1, interleukin-6) and vasodilators (such as bradykinin) have not been fully elucidated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic gas gangrene usually presents with sudden onset of severe pain at the site of surgery or trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/2,18\">",
"     2,18",
"    </a>",
"    ]. The mean incubation period is less than 24 hours (range 6 hours to several days), depending on the size of the bacterial inoculum and the extent of vascular compromise. Pain is likely related to toxin-mediated ischemia.",
"   </p>",
"   <p>",
"    The skin over the infected area initially may appear pale and then rapidly develops a bronze appearance, followed by purple or red discoloration. The skin becomes tense and exquisitely tender. Overlying bullae may be clear, red, blue or purple.",
"   </p>",
"   <p>",
"    Other necrotizing soft tissue infections, such as clostridial cellulitis and types I and II necrotizing fasciitis, may have initial presentations similar to clostridial myonecrosis.",
"   </p>",
"   <p>",
"    Signs of systemic toxicity develop rapidly including tachycardia and fever, followed by shock and multiorgan failure. In one series, shock was present in 50 percent of patients at the time of presentation to the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bacteremia occurs in about 15 percent of cases and may be associated with brisk intravascular hemolysis. One case report described a patient whose hematocrit dropped from 37 to 0 percent over a 24 hour period; despite transfusion with 10 units of packed red blood cells over four hours, the hematocrit never exceeded 7.2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/20\">",
"     20",
"    </a>",
"    ]. Both alpha and theta toxins appear to contribute to the marked intravascular hemolysis based upon studies performed with recombinant toxins in the laboratory [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/16,21\">",
"     16,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/34/6697?source=see_link&amp;anchor=H12#H12\">",
"     \"Extrinsic nonimmune hemolytic anemia due to systemic disease\", section on 'Clostridium perfringens'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bacteremia with C. perfringens can occur transiently in patients without gas gangrene, although the majority of C. perfringens and C. septicum blood isolates are associated with clinically significant infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional complications of clostridial myonecrosis include jaundice, renal failure, hypotension, and liver necrosis. Renal failure is largely due to the combined effects of hypotension, hemoglobinuria, and myoglobinuria. Bacterial toxins may also exert a direct effect on renal tubular cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain at a site of traumatic injury together with signs of systemic toxicity and gas in the soft tissue support the diagnosis of gas gangrene. Physical evidence of crepitus in the soft tissue is the most sensitive and specific finding on clinical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/24\">",
"     24",
"    </a>",
"    ]. Gas within the soft tissue can also be detected by radiography, computerized tomographic (CT) scan, or magnetic resonance imaging (MRI). Radiographic imaging can be especially useful for identifying gas in deep tissues.",
"   </p>",
"   <p>",
"    Early in the course of infection, CT and MRI are useful for determining if the infection is localized or spreading along fascial planes. Needle aspiration or punch biopsy provides an etiologic diagnosis in at least 20 percent of cases. However, these techniques should not replace thorough surgical exploration of the infected site with retrieval of specimens for Gram stain and culture.",
"   </p>",
"   <p>",
"    Definitive diagnosis of gas gangrene requires demonstration of large, gram-variable rods at the site of injury (",
"    <a class=\"graphic graphic_picture graphicRef54494 \" href=\"UTD.htm?0/39/626\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef80492 \" href=\"UTD.htm?17/13/17617\">",
"     picture 2",
"    </a>",
"    ). Although clostridia stain as gram-positive rods when obtained from culture media, the organisms can appear both gram-positive and gram-negative when stained directly from infected tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Blood cultures should also be obtained.",
"   </p>",
"   <p>",
"    Surgical exploration in the setting of traumatic gas gangrene typically demonstrates muscle that does not bleed or contract when stimulated. Muscle tissue is grossly edematous and may have reddish-blue to black discoloration. Microscopic evaluation of biopsy material invariably demonstrates organisms among degenerating muscle bundles and a characteristic absence of acute inflammatory cells (",
"    <a class=\"graphic graphic_picture graphicRef62665 \" href=\"UTD.htm?3/30/3558\">",
"     picture 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/2,27\">",
"     2,27",
"    </a>",
"    ]. When muscle is necrotic, necrosis of skin, fat, subcutaneous tissue and fascia may also be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of traumatic gas gangrene consists of surgical debridement, antibiotic therapy, and supportive measures. Prompt, aggressive, and thorough surgical inspection and debridement of devitalized tissue are mandatory to improve survival, preserve limbs, and prevent complications [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In general, multiple surgical debridements over the course of several days may be required. Other surgical interventions may also be warranted depending on individual circumstances (such as hysterectomy in patients with post partum clostridial infection) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pending definitive etiologic diagnosis of the necrotizing process, empiric antibiotic treatment should cover group A streptococcus, clostridium species, mixed aerobes and anaerobes.",
"   </p>",
"   <p>",
"    Definitive antibiotic therapy should consist of the combination of penicillin (3 to 4 million units every four hours IV) plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    (600 to 900 mg every eight hours IV) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    (500 mg every six hours IV) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/31\">",
"     31",
"    </a>",
"    ]. The combination of penicillin and clindamycin appears to be the most favorable based on animal models [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/32\">",
"     32",
"    </a>",
"    ]; clinical trials comparing the efficacy of these agents in humans have not been performed. For patients with penicillin allergy, clindamycin can be used alone.",
"   </p>",
"   <p>",
"    Antibiotic agents with excellent in vitro activity against C. perfringens include penicillin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    , and a number of cephalosporins. Studies in mice suggest that clindamycin has significantly greater activity than penicillin in experimental gas gangrene [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/28,29,32,33\">",
"     28,29,32,33",
"    </a>",
"    ]. Other agents with greater efficacy than penicillin in experimental myonecrosis models include tetracycline,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    , chloramphenicol, and metronidazole [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. The superior in vivo efficacy of clindamycin and tetracycline in these studies may be related to the ability of these agents to inhibit toxin synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/34\">",
"     34",
"    </a>",
"    ]. The diminished efficacy of penicillin may be related to ongoing toxin production by organisms that survive in filamentous form, due to the action of penicillin on cell wall formation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of hyperbaric oxygen (HBO) is controversial, largely due to the lack of data from randomized controlled trials in humans and to divergent results from studies in animals. Some nonrandomized studies have reported good results with HBO therapy when combined with antibiotics and surgical debridement [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/35\">",
"     35",
"    </a>",
"    ]. Patients that are cardiovascularly unstable may not be candidates for HBO therapy. Experimental studies in animals have failed to demonstrate therapeutic efficacy of HBO alone or the ability of HBO to enhance antibiotic efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/36\">",
"     36",
"    </a>",
"    ]. The absolute necessity of surgical debridement should not be delayed while pursuing HBO treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5448?source=see_link\">",
"     \"Hyperbaric oxygen therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Toxin inhibition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic strategies directed against toxin expression in vivo may be valuable adjuncts to traditional antimicrobial regimens. Antitoxin for passive immunotherapy is not available; active immunization of experimental animals with the cell-binding domain of alpha toxin is 100 percent protective against a lethal challenge with C. perfringens [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Future treatment strategies may include attenuation of toxin-induced vascular leukostasis and resultant tissue injury by targeting endogenous proadhesive molecules, and reducing duration and severity of shock via anti-cytokine molecules.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for gas gangrene of an extremity is more favorable than gas gangrene of the trunk or visceral organs since gangrene of an extremity may be debrided more readily [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/19,28,29\">",
"     19,28,29",
"    </a>",
"    ]. Patients with associated bacteremia and intravascular hemolysis have the greatest likelihood of progressing to shock and death. Mortality is highest for patients in shock at the time of diagnosis. In a series of 139 patients treated with antibiotics, surgery, and hyperbaric oxygen, 67 were in shock at admission and all deaths (27 patients) occurred in this subset [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/19\">",
"     19",
"    </a>",
"    ]. Overall survival was 81 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial aggressive debridement of devitalized tissue can reduce the risk of gas gangrene in contaminated deep wounds. Interventions to be avoided include prolonged application of tourniquets and surgical closure of traumatic wounds; patients with compound fractures are at significant risk for gas gangrene if the wound is closed surgically [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vaccination against alpha toxin is protective in experimental animal models [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/5,6\">",
"     5,6",
"    </a>",
"    ] but has not been investigated in humans.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SPONTANEOUS GAS GANGRENE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous gas gangrene generally occurs via hematogenous seeding of muscle with bacteria (usually Clostridium septicum) from a gastrointestinal tract portal of entry. The diagnosis of spontaneous gas gangrene is frequently missed or delayed because it is not entertained. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Clinical manifestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    C. septicum has also been transmitted from contaminated musculoskeletal allografts (tendons, menisci, femoral condyles) harvested from cadaveric tissues. In a report of 14 such cases, all came from a single tissue bank in which the rate of infection was 0.07 percent among more than 20,000 allografts [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    C. tertium has also been associated with spontaneous myonecrosis. It can grow aerobically so may be mistaken for a contaminant such as a diphtheroid or bacillus species [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The organism's resistance to penicillin, cephalosporins, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    may facilitate survival in the gastrointestinal tract, especially in patients receiving broad-spectrum antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. septicum can grow in normal tissues; unlike C. perfringens, it does not require anaerobic conditions. The presence of a gastrointestinal lesion facilitates entry of the organism into the bloodstream and then into other tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    C. septicum produces multiple exotoxins, including [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Alpha toxin (a lethal, hemolytic, necrotizing toxin)",
"     </li>",
"     <li>",
"      Beta toxin (DNase)",
"     </li>",
"     <li>",
"      Gamma toxin (hyaluronidase)",
"     </li>",
"     <li>",
"      Delta toxin (septicolysin, an oxygen labile hemolysin)",
"     </li>",
"     <li>",
"      A protease",
"     </li>",
"     <li>",
"      A neuraminidase",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mechanism by which the alpha toxin of C. septicum contributes to pathogenesis is unknown; unlike the alpha toxin of C. perfringens, the alpha toxin of C. septicum does not possess phospholipase activity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous gas gangrene usually presents with abrupt onset of severe muscle pain. Occasionally only heaviness or numbness is reported [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/1,2,40-42\">",
"     1,2,40-42",
"    </a>",
"    ]. In some patients the first manifestation may be confusion or malaise.",
"   </p>",
"   <p>",
"    Infection progresses rapidly with development of edema and bullae filled with clear, cloudy, hemorrhagic, or purplish fluid. The skin around the bullae has a purple hue, perhaps reflecting vascular compromise resulting from bacterial toxins diffusing into surrounding tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/40\">",
"     40",
"    </a>",
"    ]. Histopathology of muscle and connective tissues demonstrates cell lysis and gas formation. As with C. perfringens gas gangrene, inflammatory cells are absent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Predisposing factors include [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Colonic malignancy",
"     </li>",
"     <li>",
"      Inflammatory bowel disease",
"     </li>",
"     <li>",
"      Diverticulitis",
"     </li>",
"     <li>",
"      Gastrointestinal surgery",
"     </li>",
"     <li>",
"      Leukemia",
"     </li>",
"     <li>",
"      Lymphoproliferative disorders",
"     </li>",
"     <li>",
"      Chemotherapy",
"     </li>",
"     <li>",
"      Neutropenia",
"     </li>",
"     <li>",
"      Radiation therapy",
"     </li>",
"     <li>",
"      AIDS",
"     </li>",
"     <li>",
"      Necrotizing enterocolitis, cecitis, or distal ileitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever and severe pain in an extremity (in the absence of trauma) should raise suspicion for spontaneous gas gangrene. Distinguishing spontaneous gas gangrene due to clostridia from streptococcal myositis may be difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/40\">",
"     40",
"    </a>",
"    ]. The presence of tissue crepitus favors clostridial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69941 \" href=\"UTD.htm?10/54/11106\">",
"     image 1",
"    </a>",
"    ). Gas within the soft tissue can also be detected by radiography, computerized tomographic (CT) scan or magnetic resonance imaging (MRI).",
"   </p>",
"   <p>",
"    As with traumatic gas gangrene, definitive diagnosis of spontaneous gas gangrene requires demonstration of large, gram-variable rods at the site of injury. Gram stain of bullous fluid may also be useful. Blood cultures should also be obtained since bacteremia in C. septicum gangrene usually precedes cutaneous manifestations by several hours.",
"   </p>",
"   <p>",
"    Surgical findings are as described for traumatic gas gangrene (",
"    <a class=\"graphic graphic_picture graphicRef54494 \" href=\"UTD.htm?0/39/626\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef80492 \" href=\"UTD.htm?17/13/17617\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef62665 \" href=\"UTD.htm?3/30/3558\">",
"     picture 3",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of spontaneous gas gangrene consists of early surgical debridement and antibiotic therapy. Urgent, thorough surgical debridement is mandatory to improve survival, preserve limbs, and prevent complications [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Multiple surgical debridements may be required.",
"   </p>",
"   <p>",
"    Antibiotic therapy for treatment of spontaneous gas gangrene due to C. septicum should consist of the combination of penicillin (3 to 4 million units every four hours IV) plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    (600 to 900 mg every eight hours IV) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    (500 mg every six hours IV). This approach is extrapolated from the treatment of traumatic gas gangrene due to C. perfringens and is based on animal models; no human trials have compared the efficacy of antibiotics for treatment of spontaneous gas gangrene. Antibiotic agents with excellent in vitro activity against both C. septicum and C. perfringens include penicillin, tetracycline,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    , clindamycin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    . As with C. perfringens infection, agents that inhibit exotoxin production would likely have greater efficacy in vivo than cell wall-active antibiotics. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Treatment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    C. tertium is resistant to penicillin, cephalosporins and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/28\">",
"     28",
"    </a>",
"    ]. Appropriate therapy for C. tertium infection is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (1 g every 12 hours IV) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    (500 mg every eight hours IV).",
"   </p>",
"   <p>",
"    The use of hyperbaric oxygen (HBO) is controversial. Since C. septicum is capable of growth in aerobic conditions, the efficacy of HBO for treatment of spontaneous gas gangrene may be limited [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who survive spontaneous gangrene should have colonoscopy to rule out associated pathology of the gastrointestinal tract.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality of spontaneous gangrene ranges from 67 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12264/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. The majority of deaths occur within 24 hours of onset. Risk factors for a fatal outcome include underlying malignancy and immunocompromised state.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/13/210?source=see_link\">",
"       \"Patient information: Gangrene (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clostridial myonecrosis (gas gangrene) is a life-threatening muscle infection that develops either contiguously from an area of trauma (usually due to C. perfringens) or hematogenously from the gastrointestinal tract with muscle seeding (usually due to C. septicum). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Traumatic wounds with vascular compromise (particularly deep penetrating injuries such as knife wounds, gunshot wounds, and crush injuries) create an anaerobic environment that is ideal for proliferation of clostridia. Most cases are caused by C. perfringens. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Traumatic gas gangrene'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gas gangrene usually presents with sudden onset of severe muscle pain. The skin initially may appear pale and then rapidly develops a bronze appearance, followed by purple or red discoloration. The skin becomes tense and exquisitely tender and may have overlying bullae. Signs of systemic toxicity develop rapidly including fever and tachycardia, followed by shock and multiorgan failure. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Definitive diagnosis of gas gangrene requires demonstration of large, gram-variable rods at the site of injury. Histopathology demonstrates characteristic absence of acute inflammatory cells. Gas in the soft tissue may be observed at the bedside",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      radiographically. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of traumatic gas gangrene consists of aggressive and thorough surgical debridement together with antibiotic therapy. We suggest the following antibiotic regimen: penicillin (3 to 4 million units every four hours IV) together with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (600 to 900 mg every eight hours IV) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For patients with penicillin allergy, clindamycin can be used alone.",
"     </li>",
"     <li>",
"      The value of hyperbaric oxygen (HBO) is controversial, though some nonrandomized observational studies have reported good results with HBO in combination with antibiotics and surgical debridement. However, the absolute necessity of surgical intervention should not be delayed while pursuing HBO therapy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/1\">",
"      Awad MM, Bryant AE, Stevens DL, Rood JI. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol 1995; 15:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/2\">",
"      MACLENNAN JD. The histotoxic clostridial infections of man. Bacteriol Rev 1962; 26:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Update: Clostridium novyi and unexplained illness among injecting-drug users--Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000; 49:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/4\">",
"      Stevens DL, Laposky LL, McDonald P, Harris I. Spontaneous gas gangrene at a site of remote injury--localization due to circulating antitoxin. West J Med 1988; 148:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/5\">",
"      Williamson ED, Titball RW. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine 1993; 11:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/6\">",
"      Stevens DL, Titball RW, Jepson M, et al. Immunization with the C-Domain of alpha -Toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens. J Infect Dis 2004; 190:767.",
"     </a>",
"    </li>",
"    <li>",
"     Alouf, JE, Geoffroy, C. The Family of the Antigenically-Related, Cholesterol-Binding (\"Sulphydryl-Activated\") Cytolytic Toxins. In: Alouf JE, Freer JH, eds. Sourcebook of Bacterial Protein Toxins. New York: Academic Press, 1991. p. 147.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/8\">",
"      Bryant AE, Bergstrom R, Zimmerman GA, et al. Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol Med Microbiol 1993; 7:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/9\">",
"      Bryant AE, Stevens DL. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun 1996; 64:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/10\">",
"      Stevens DL, Tweten RK, Awad MM, et al. Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J Infect Dis 1997; 176:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/11\">",
"      McNee, JW, Dunn, JS. The method of spread of gas gangrene into living muscle. Br Med J 1917; 1:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/12\">",
"      Robb-Smith, AHT. Tissues changes induced by C. welchii type a filtrates. Lancet 1945; 2:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/13\">",
"      Bryant AE, Chen RY, Nagata Y, et al. Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis 2000; 182:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/14\">",
"      Bryant AE, Chen RY, Nagata Y, et al. Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis 2000; 182:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/15\">",
"      Stevens DL, Troyer BE, Merrick DT, et al. Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens. J Infect Dis 1988; 157:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/16\">",
"      Asmuth DM, Olson RD, Hackett SP, et al. Effects of Clostridium perfringens recombinant and crude phospholipase C and theta-toxin on rabbit hemodynamic parameters. J Infect Dis 1995; 172:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/17\">",
"      Whatley RE, Nelson P, Zimmerman GA, et al. The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. J Biol Chem 1989; 264:6325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/18\">",
"      Weinstein L, Barza MA. Gas gangrene. N Engl J Med 1973; 289:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/19\">",
"      Hart GB, Lamb RC, Strauss MB. Gas gangrene. J Trauma 1983; 23:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/20\">",
"      Terebelo HR, McCue RL, Lenneville MS. Implication of plasma free hemoglobin in massive clostridial hemolysis. JAMA 1982; 248:2028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/21\">",
"      H&uuml;bl W, Mostbeck B, Hartleb H, et al. Investigation of the pathogenesis of massive hemolysis in a case of Clostridium perfringens septicemia. Ann Hematol 1993; 67:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/22\">",
"      Gorbach SL, Thadepalli H. Isolation of Clostridium in human infections: evaluation of 114 cases. J Infect Dis 1975; 131 Suppl:S81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/23\">",
"      Brook I. Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. J Infect Dis 1989; 160:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/24\">",
"      Gozal D, Ziser A, Shupak A, et al. Necrotizing fasciitis. Arch Surg 1986; 121:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/25\">",
"      Butler, HM. Pathogenicity of washed C. welchii and mode of development C. welchii infections in man. Med J Aust 1943; 2:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/26\">",
"      Keppie, J, Robertson, M. The in vitro toxigenicity and other characters of strains of C.welchii type A from various sources. J Pathol Bacteriol 1944; 56:123.",
"     </a>",
"    </li>",
"    <li>",
"     Stevens DL. Clostridial infections. In: Stevens DL, Mandell GL, Atlas of Infectious Diseases (Ed), Churchill Livingstone, Philadelphia 1995. p.13.1.",
"    </li>",
"    <li>",
"     Gorbach, SL. Clostridium perfringens and other clostridia. In: Infectious Diseases, Gorbach, SL, Bartlett, JG, Blacklow, NR (Eds), WB Saunders, Philadelphia 1992. p.1587.",
"    </li>",
"    <li>",
"     Lorber B. Gas gangrene and other Clostridium-associated diseases. In: Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.2828.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/30\">",
"      Dylewski J, Wiesenfeld H, Latour A. Postpartum uterine infection with Clostridium perfringens. Rev Infect Dis 1989; 11:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/31\">",
"      Altemeier WA, Fullen WD. Prevention and treatment of gas gangrene. JAMA 1971; 217:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/32\">",
"      Stevens DL, Laine BM, Mitten JE. Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens. Antimicrob Agents Chemother 1987; 31:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/33\">",
"      Stevens DL, Maier KA, Laine BM, Mitten JE. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis 1987; 155:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/34\">",
"      Stevens DL, Maier KA, Mitten JE. Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agents Chemother 1987; 31:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/35\">",
"      Kaide CG, Khandelwal S. Hyperbaric oxygen: applications in infectious disease. Emerg Med Clin North Am 2008; 26:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/36\">",
"      Stevens DL, Bryant AE, Adams K, Mader JT. Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clin Infect Dis 1993; 17:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/37\">",
"      Drake, WG, King, AM, Slack, WK. Gas gangrene and related infection: classification, clinical features and etiology, management and mortality. Br J Surg 1977; 64:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/38\">",
"      Kainer MA, Linden JV, Whaley DN, et al. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 2004; 350:2564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/39\">",
"      Ballard J, Bryant A, Stevens D, Tweten RK. Purification and characterization of the lethal toxin (alpha-toxin) of Clostridium septicum. Infect Immun 1992; 60:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/40\">",
"      Stevens DL, Musher DM, Watson DA, et al. Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev Infect Dis 1990; 12:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/41\">",
"      Johnson S, Driks MR, Tweten RK, et al. Clinical courses of seven survivors of Clostridium septicum infection and their immunologic responses to alpha toxin. Clin Infect Dis 1994; 19:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/42\">",
"      Alpern RJ, Dowell VR Jr. Clostridium septicum infections and malignancy. JAMA 1969; 209:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/43\">",
"      Yoder EL, Mendez J, Khatib R. Spontaneous gangrenous myositis induced by Streptococcus pyogenes: case report and review of the literature. Rev Infect Dis 1987; 9:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/44\">",
"      Arteta-Bulos R, Karim SM. Images in clinical medicine. Nontraumatic Clostridium septicum myonecrosis. N Engl J Med 2004; 351:e15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/45\">",
"      Hill GB, Osterhout S. Experimental effects of hyperbaric oxygen on selected clostridial species. II. In-vitro studies in mice. J Infect Dis 1972; 125:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/46\">",
"      Nordkild P, Crone P. Spontaneous clostridial myonecrosis. A collective review and report of a case. Ann Chir Gynaecol 1986; 75:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12264/abstract/47\">",
"      Bodey GP, Rodriguez S, Fainstein V, Elting LS. Clostridial bacteremia in cancer patients. A 12-year experience. Cancer 1991; 67:1928.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7672 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-4327E6E395-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12264=[""].join("\n");
var outline_f11_62_12264=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SPECTRUM OF CLOSTRIDIAL INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TRAUMATIC GAS GANGRENE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      C. perfringens toxins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Toxin inhibition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SPONTANEOUS GAS GANGRENE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7672\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7672|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/54/11106\" title=\"diagnostic image 1\">",
"      Clostridial myonecrosis computed tomography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7672|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/39/626\" title=\"picture 1\">",
"      C perfringens Gram stain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/13/17617\" title=\"picture 2\">",
"      Clostridia in muscle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/30/3558\" title=\"picture 3\">",
"      Gas gangrene in muscle",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/34/6697?source=related_link\">",
"      Extrinsic nonimmune hemolytic anemia due to systemic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5448?source=related_link\">",
"      Hyperbaric oxygen therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=related_link\">",
"      Necrotizing soft tissue infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5449?source=related_link\">",
"      Pathophysiology of sepsis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/13/210?source=related_link\">",
"      Patient information: Gangrene (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32950?source=related_link\">",
"      Pyomyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44710?source=related_link\">",
"      Vibrio vulnificus infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_62_12265="HHV-6 encephalitis MRI 2";
var content_f11_62_12265=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F83216&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F83216&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 533px\">",
"   <div class=\"ttl\">",
"    Post-transplant acute limbic encephalitis caused by HHV-6 - coronal FLAIR magnetic resonance images",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 513px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal FLAIR MR images demonstrate the focality of the encephalitis, which can be traced bilaterally from the uncus through the hippocampal body and into the fornix. The amygdala is partly affected and the parahippocampal gyrus is conspicuously spared. The left side of each image corresponds to the right side of the brain.",
"    <div class=\"footnotes\">",
"     HHV-6: human herpesvirus 6; FLAIR: fluid attenuation inversion recovery",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Seeley WW, Marty FM, Holmes TH, et al. Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6. Neurology 2007; 69:156. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12265=[""].join("\n");
var outline_f11_62_12265=null;
var title_f11_62_12266="Mechanisms of atrial fibrillation";
var content_f11_62_12266=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mechanisms of atrial fibrillation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12266/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12266/contributors\">",
"     Brian Olshansky, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12266/contributors\">",
"     Rishi Arora, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12266/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12266/contributors\">",
"     Bradley P Knight, MD, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12266/contributors\">",
"     Hugh Calkins, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/62/12266/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/62/12266/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/62/12266/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H8807144\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial fibrillation is a most common cardiac arrhythmia. The chance of developing atrial fibrillation is tied closely to age, with AF rare before the age of 50 years. In addition to age, there are many types of cardiac and medical conditions that are also closely linked to AF. These include hypertension, coronary artery disease, heart failure, valvular heart disease, obesity, and sleep-apnea syndrome. It is also well established that very high levels of alcohol can increase the probability of developing AF, and that hyperthyroidism can cause AF. Finally, it is also well established that AF is more common in individuals who have a first-degree relative who developed AF at a young age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=see_link\">",
"     \"Epidemiology of and risk factors for atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The precise mechanisms by which age and the other conditions listed above increase the propensity for development of AF are understood poorly (",
"    <a class=\"graphic graphic_figure graphicRef63675 \" href=\"UTD.htm?31/9/31890\">",
"     figure 1",
"    </a>",
"    ). However these conditions may impact the triggers for AF, which commonly arise in the pulmonary veins or the substrate for maintenance of AF, which broadly relates to atrial size and the extent of fibrosis. Some of the factors that may play a role in the mechanisms of AF include autonomic tone, inflammation, atrial pressure and wall stress, and genetics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=see_link&amp;anchor=H25#H25\">",
"     \"Epidemiology of and risk factors for atrial fibrillation\", section on 'Other factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will provide a broad overview of the current understanding of the mechanisms of AF. This discussion will provide a relatively simplistic approach to a complex topic. The reader will be referred to a rapidly growing literature on this topic, including some comprehensive reviews [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186292585\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following terms are defined to help the reader&rsquo;s understanding of the material below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Trigger  a rapidly firing focus often arising the in the pulmonary veins that can initiate AF",
"     </li>",
"     <li>",
"      Triggered activity  One of three mechanisms of cardiac arrhythmias (including automaticity and reentry). Triggered activity refers to additional depolarizations, which occur during or immediately following a cardiac depolarization and may cause a sustained cardiac arrhythmia.",
"     </li>",
"     <li>",
"      Substrate  mechanical and anatomic structure of the atria in which AF can occur",
"     </li>",
"     <li>",
"      Substrate remodeling  changes in the mechanical and anatomic macro, micro, and ultra structure of the atrial substrate that result from the development of AF and increase the propensity for the development and maintenance of AF over time",
"     </li>",
"     <li>",
"      Electrical remodeling  changes in the atrial electrical properties (refractoriness and conduction) that result from the development of AF and increase the propensity for the development and maintenance of AF over time",
"     </li>",
"     <li>",
"      Dispersion of refractoriness  a range of differences in the refractory period properties throughout the atrial tissue",
"     </li>",
"     <li>",
"      Spatial heterogeneity of refractoriness  dispersion of refractoriness manifest as variability in refractoriness throughout the atrial anatomy",
"     </li>",
"     <li>",
"      Complex fractionated electrograms  local electrograms obtained from areas of the atrium that are rapid, of low amplitude, and have multiple components",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Reentry/reentrant",
"      </span>",
"      mechanism  One of three mechanisms of cardiac arrhythmias (including automaticity and triggered activity). Reentry is the most common mechanism of cardiac arrhythmias and refers to the presence of one or more electrical circuit(s) in which electrical activation proceeds in a circular fashion to complete a self-sustaining circuit. &nbsp;",
"     </li>",
"     <li>",
"      Atrial anisotropy  conduction properties related to directionality of conduction through atrial tissue. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186294596\">",
"    <span class=\"h1\">",
"     BASIC ATRIAL ELECTROPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrophysiologic properties of normal and fibrillating atria have been studied extensively [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/2\">",
"     2",
"    </a>",
"    ]. A basic understanding of these properties is necessary to understand the pathologic processes that play a role in initiating and perpetuating AF. In the aggregate, these electrophysiologic properties permit the development of very complex patterns of conduction and an extremely rapid atrial rate as seen in AF.",
"   </p>",
"   <p>",
"    The atrial myocardium consists of so-called \"fast-response\" tissues that depend on the rapidly activating sodium current for phase 0 of the action potential. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=see_link\">",
"     \"Myocardial action potential and action of antiarrhythmic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Normal atrial myocardium has the following properties [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A short action-potential duration",
"     </li>",
"     <li>",
"      Cellular reactivation can occur rapidly due to the short refractory period (in contrast to Purkinje fibers and ventricular muscle)",
"     </li>",
"     <li>",
"      Very rapid electrical conduction can occur",
"     </li>",
"     <li>",
"      The refractory period shortens with increasing rate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the aggregate, these electrophysiologic properties permit the development of very complex patterns of conduction and an extremely rapid atrial rate as seen in AF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186292593\">",
"    <span class=\"h1\">",
"     CLINICAL FACTORS ASSOCIATED WITH AF",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following are common clinical conditions associated with AF in developed countries, and the percent of AF cases in which they are found (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology of and risk factors for atrial fibrillation\", section on 'Disease associations'",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypertension (60 to 80 percent)",
"     </li>",
"     <li>",
"      Cardiovascular disease, including cardiomyopathy, valvular and coronary artery disease (25 to 30 percent)",
"     </li>",
"     <li>",
"      New York Heart Association class II-IV heart failure (30 percent)",
"     </li>",
"     <li>",
"      Diabetes (20 percent)",
"     </li>",
"     <li>",
"      Age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Each of the first three is associated with left atrial dilatation, which is important in the development of a substrate for AF and also may increase the probability of electrical firing from the pulmonary veins. (See",
"    <a class=\"local\" href=\"#H11423999\">",
"     'Mechanisms of atrial fibrillation: triggers and substrates'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The following section will discuss the link between these conditions and AF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11423999\">",
"    <span class=\"h1\">",
"     MECHANISMS OF ATRIAL FIBRILLATION: TRIGGERS AND SUBSTRATES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial fibrillation may present as a paroxysmal (self-terminating AF within seven days), a persistent (one that lasts greater than seven days or requires termination by a drug or cardioversion electrically), or a long-standing persistent AF (continuous AF for 12 months or greater). The term permanent AF should be used when both the patient and physicians agree to not pursue strategies to restore or maintain sinus rhythm. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of atrial fibrillation\", section on 'Classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This wide range of clinical presentations is likely due to an interaction between a trigger and the substrate (",
"    <a class=\"graphic graphic_figure graphicRef63675 \" href=\"UTD.htm?31/9/31890\">",
"     figure 1",
"    </a>",
"    ). AF is initiated by rapid firing (or triggers) from the pulmonary veins (PV). Early in the course of AF the atrium is relatively healthy and as a result sinus rhythm is spontaneously restored. As the substrate remodels further over time, atrial fibrillation no longer terminates spontaneously and becomes persistent. With more extensive remodeling of the atrium it becomes increasingly difficult to maintain sinus rhythm and the patient and physician may agree no longer to attempt to maintain sinus rhythm, with the AF thereby being considered permanent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186294961\">",
"    <span class=\"h2\">",
"     Triggers of AF",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been known for many years that a single focus firing rapidly in the atria can be a trigger for fibrillatory conduction throughout the atria [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/6\">",
"     6",
"    </a>",
"    ]. It is now well established that the most common site of the rapid atrial firing that triggers AF is the pulmonary veins. Catheter ablation of AF depends in large part on the electrical isolation of the PVs from the remainder of the atrium. Electrophysiologic evaluation of the pulmonary veins has identified myocardial tissue that can lead to repetitive firing or even the presence of episodic reentrant activation in the veins [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additionally, stretch can increase the propensity for rapid firing from the PVs as a result of stretch sensitive ion channels. [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/7\">",
"     7",
"    </a>",
"    ]. It has been speculated that the mechanism of atrial stretch may help explain the association between AF and mitral regurgitation as well as various types of heart failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8804369\">",
"    <span class=\"h3\">",
"     Role of atrial premature beats and other arrhythmia triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;AF is initiated (triggered) predominantly by rapid firing from the pulmonary veins (PV). Much less commonly, AF can be triggered by non-PV sites of rapid firing (such as tissue near the PV, the superior vena cava, or coronary sinus) or by other types of supraventricular arrhythmias including atrioventricular nodal reentrant tachycardia (AVNRT), orthodromic atrioventricular (AV) reciprocating tachycardia, and atrial flutter [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/1,8-18\">",
"     1,8-18",
"    </a>",
"    ]. In some patients, successful elimination of AF with catheter ablation requires both isolation of the PVs, as well as elimination of these non-PV triggers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/45/37591?source=see_link\">",
"     \"Surgical approaches to prevent recurrent atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186294723\">",
"    <span class=\"h3\">",
"     Role of atrial flutter and SVT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial tachycardia, atrial flutter, and other supraventricular tachycardias can initiate AF in predisposed patients. The interaction between these arrhythmias and AF is not well understood, but atrial flutter and AF commonly coexist.",
"   </p>",
"   <p>",
"    In some instances, elimination of atrial flutter will diminish",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    eliminate episodes of AF. Nevertheless, elimination of the right atrial reentry circuit responsible for typical flutter frequently does not eliminate the predisposition to AF that is predominately a left-atrial problem in a large number of patients. Many studies have demonstrated that patients who undergo catheter ablation of typical atrial flutter have a very high probability of developing atrial fibrillation over the ensuing five years. This is true regardless of whether atrial fibrillation had been observed prior to development of typical atrial flutter. This has clinical implications when it comes to ablation, but also has implications for patient follow-up. Nevertheless, it makes sense to try to eliminate the organized supraventricular tachycardia, especially if right-sided by ablation before considering PV isolation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other more extensive ablation procedures to eliminate AF, as the AF may be reduced or eliminated by eliminating the other tachycardia first.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186294983\">",
"    <span class=\"h2\">",
"     Maintenance of AF",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with persistent AF, the prevailing understanding of the mechanism is that, once triggered, the arrhythmia is maintained (sustained) by one or more abnormalities in the atrial tissue. This process may explain why the failure rate of pulmonary vein isolation is as high as 40 to 60 percent at one year: The trigger(s) may have been treated but not the abnormalities that sustain AF once triggered (initiated).",
"   </p>",
"   <p>",
"    The role of localized sources (electrical rotors and focal impulses) in the initiation and maintenance of AF was explored in the CONFIRM trial of 92 patients undergoing ablation procedures for paroxysmal or persistent (72 percent) AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/19\">",
"     19",
"    </a>",
"    ]. Consecutive patients were prospectively treated (not randomly assigned) in a 1:2 case-cohort design with either conventional ablation at sources identified within the atria followed by conventional ablation or conventional ablation alone. Localized sources were identified in 97 percent of cases (70 percent rotors and 30 percent focal impulses) with sustained AF, each with an average of 2.1 sources. During a median of 273 days, patients treated with treatment of both sources and conventional ablation had a significantly higher freedom from AF (82.4 versus 44.9 percent).",
"    <br/>",
"   </p>",
"   <p>",
"    The following sections describe factors that might contribute to the maintenance of AF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8621795\">",
"    <span class=\"h3\">",
"     Atrial remodeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial remodeling involves the concept that there are structural changes, such as fibrosis, or electrical changes, such as refractory-period dispersion or conduction display, in the atria that can predispose to the development and maintenance of AF. In some instances, structural and electrical changes occur simultaneously. These processes can facilitate or create electrical reentrant circuits or triggers that can lead to AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/8,20\">",
"     8,20",
"    </a>",
"    ]. It is also well established that the presence of atrial fibrillation results in remodeling of the atrium over time [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/2\">",
"     2",
"    </a>",
"    ]. This explains the well-established concept that AF begets AF (",
"    <a class=\"graphic graphic_figure graphicRef51670 \" href=\"UTD.htm?20/50/21280\">",
"     figure 2",
"    </a>",
"    ). Thus the longer a patient has been in continuous AF, the less likely it is to terminate spontaneously, and harder it is to restore and maintain sinus rhythm.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186295411\">",
"    <span class=\"h3\">",
"     Electrical remodeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paroxysmal AF commonly precedes chronic AF. It has been suggested even after only a few minutes, AF induces transient changes in atrial electrophysiology that promote its perpetuation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/9\">",
"     9",
"    </a>",
"    ]. This might occur through a tachycardiomyopathy or through \"electrical remodeling\" of the atria by AF, leading to a progressive decrease in atrial refractoriness [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Electrical remodeling results from the high rate of electrical activation, which stimulates the AF-induced changes in refractoriness [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/21\">",
"     21",
"    </a>",
"    ]. Tachycardia-induced changes in refractoriness are spatially nonuniform and there is increased variability both within and among various atrial regions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/22\">",
"     22",
"    </a>",
"    ]. It is possible that the change in atrial refractory period observed after an episode of AF predisposes to the spontaneous recurrence of AF in the days following cardioversion.",
"   </p>",
"   <p>",
"    In addition to the shortening of the refractory period, chronic, rapid, atrial pacing-induced AF results in other changes within the atria, including an increase in the expression and distribution of connexin 43 and heterogeneity in the distribution of connexin 40, both of which are intercellular gap junction proteins (\"gap junctional remodeling\") [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]; cellular remodeling is due to apoptotic death of myocytes with myolysis, which may not be entirely reversible [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/13\">",
"     13",
"    </a>",
"    ]; the induction of sinus node dysfunction, demonstrated by prolonged corrected sinus node recovery time, reduced maximal heart rate in response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    , and lower intrinsic heart rate after administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/14\">",
"     14",
"    </a>",
"    ]; and an increase in P wave duration and intraatrial conduction time.",
"   </p>",
"   <p>",
"    A clinical study evaluated the hypothesis of electrical remodeling by the use of atrial pacing-induced AF in patients with a history of supraventricular tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/15\">",
"     15",
"    </a>",
"    ]. AF significantly shortened the right-atrial effective refractory period after only a few minutes, and temporal recovery of the refractory period occurred over about eight minutes. Upon termination of AF, there was an increased propensity for the induction of another episode of AF that decreased with increasing time after the initial AF reversion. The second also tends to last longer than the first.",
"   </p>",
"   <p>",
"    The time to recurrence was also evaluated in a review of 61 patients who had daily ECG recordings using transtelephonic monitoring: 57 percent had recurrent AF during the first month after cardioversion, with a peak incidence during the first five days [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/16\">",
"     16",
"    </a>",
"    ]. Among patients with recurrence there was a positive correlation between the duration of the shortest coupling interval of atrial premature beats after cardioversion, which correlates with the refractory period and the timing of recurrence (",
"    <a class=\"graphic graphic_figure graphicRef60431 \" href=\"UTD.htm?25/2/25645\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22426?source=see_link\">",
"     \"Restoration of sinus rhythm in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast to the normal situation in which the atrial refractory period shortens with an increase in rate (as in AF) and prolongs when the rate decreases, the refractory period fails to lengthen appropriately at slow rates (eg, with return to sinus rhythm) in patients with acute or chronic AF. The duration of AF has no significant impact upon the extent of these electrophysiologic changes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Atrial electrical remodeling is reversed gradually after the restoration of sinus rhythm [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/18,23\">",
"     18,23",
"    </a>",
"    ]. This may be one of the explanations for the early or immediate return of AF after cardioversion. In one study of 25 patients, the atrial refractory period increased and the adaptation of atrial refractoriness to rate was normal by four weeks after cardioversion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/18\">",
"     18",
"    </a>",
"    ]. In another report of 38 patients, the atrial refractory period increased by one week, with some variation in different regions of the atrium [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/23\">",
"     23",
"    </a>",
"    ]. This observation has important clinical implications. &nbsp;",
"   </p>",
"   <p>",
"    The mechanism for electrical remodeling and shortening of the atrial refractory period is not entirely clear; a possible explanation is ion-channel remodeling, with a decrease in the protein content of the L-type calcium channel [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/24\">",
"     24",
"    </a>",
"    ]. Support for this comes from an animal study in which",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    , an L-type calcium antagonist, prevented electric remodeling of short-duration AF (one day or less) and hastened complete recovery, without affecting inducibility of AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/25\">",
"     25",
"    </a>",
"    ]. Similar findings have been noted in humans as verapamil, but not",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    , prevented remodeling when given prior to the electrophysiologic induction of AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/26\">",
"     26",
"    </a>",
"    ]. Oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    is also effective in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/27\">",
"     27",
"    </a>",
"    ], while beta blockers had no effect on electrical remodeling in an animal model [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In comparison, cytosolic calcium overload, induced by hypercalcemia or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    , which increases the intracellular concentration of calcium by activating the sodium-calcium exchanger, enhances electrical remodeling [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/25,28,29\">",
"     25,28,29",
"    </a>",
"    ]. The effect of digoxin, which is not due to its vagotonic activity, is associated with an increase in the inducibility and duration of AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Calcium leak from the sarcoplasmic reticulum may trigger and maintain AF. It is known that protein kinase A (PKA) hyperphosphorylation of the cardiac ryanodine receptor (RyR2), resulting in dissociation of the channel-stabilizing subunit calstabin2, causes SR calcium leak in failing hearts. This phenomenon seems to be involved in triggering ventricular arrhythmias.",
"   </p>",
"   <p>",
"    Using similar logic, these proteins were investigated in atrial tissues from both dogs and humans with AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/30\">",
"     30",
"    </a>",
"    ]. Atrial tissue in those with AF showed a significant increase in PKA phosphorylation of RyR2 and a decrease in calstabin2 binding to the channel. Channels isolated from dogs with AF had an increased open probability under conditions simulating diastole compared with channels from control hearts, suggesting that these AF channels could predispose to a diastolic SR calcium leak. The conclusion was that SR calcium leak due to RyR2 PKA hyperphosphorylation may play a role in the initiation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    maintenance of AF.",
"   </p>",
"   <p>",
"    The effects of calcium overload are quite complex. It is likely that triggers and substrates initiate short episodes of AF that then lead to calcium overload and over a period of minutes there is an in activation of the I",
"    <sub>",
"     Ca",
"    </sub>",
"    ,L current that increases I",
"    <sub>",
"     K1",
"    </sub>",
"    , decreases I",
"    <sub>",
"     Na",
"    </sub>",
"    , increases I",
"    <sub>",
"     KACh",
"    </sub>",
"    and decreases I",
"    <sub>",
"     TO",
"    </sub>",
"    . This can affect the action-potential duration and allow for more reentry to occur. As reentry occurs, the substrate changes and there is remodeling through calcium handling abnormalities as well as mRNA transcription, and ultimately perhaps with protein decrease, changes in connexons, including, Cx40, that can affect conduction. The calcium-handling abnormalities can also lead to hypotension tract ability and atrial dilatation, thereby affecting even more the possibility of developing AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both animal and human studies suggest that angiotensin II is involved in electrical and atrial myocardial remodeling [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/32,33\">",
"     32,33",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36825?source=see_link\">",
"     \"Actions of angiotensin II on the heart\"",
"    </a>",
"    ). In an animal model, inhibition of angiotensin II with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/48/38663?source=see_link\">",
"     candesartan",
"    </a>",
"    prevented shortening of the atrial effective refractory period and atrial electrical remodeling during rapid atrial pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/32\">",
"     32",
"    </a>",
"    ], while atrial tissue obtained during open heart surgery from patients with AF revealed downregulation of AT1 receptor proteins and upregulation of AT2 receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/33\">",
"     33",
"    </a>",
"    ]. The potential clinical importance of these changes is illustrated by the observations that ACE inhibitors reduce the incidence of AF in patients with left ventricular dysfunction after myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/34\">",
"     34",
"    </a>",
"    ] and in patients with chronic left ventricular dysfunction due to ischemic heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26088?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another possible contributor to electrical remodeling and shortening of the atrial refractory period is atrial ischemia, which activates the",
"    <span class=\"nowrap\">",
"     sodium/hydrogen",
"    </span>",
"    exchanger. The intravenous administration of HOE 642, a selective inhibitor of this sodium proton pump, to dogs undergoing rapid atrial pacing resulted in the lengthening of atrial refractoriness after one hour, while control dogs showed effective refractory-period shortening greater than 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8804397\">",
"    <span class=\"h3\">",
"     Role of the autonomic nervous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is increasingly well recognized that the autonomic nervous system plays an important role in the development and maintenance of AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. Both the parasympathetic and the sympathetic nervous system have been implicated in the genesis of AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. Early epidemiologic studies suggested that exercise-induced AF may be sympathetically driven [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/43\">",
"     43",
"    </a>",
"    ]. The parasympathetic nervous system is thought to contribute to AF in young patients with no structural heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/44\">",
"     44",
"    </a>",
"    ]. The following recent studies further support a role for the autonomic nervous system in the genesis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    maintenance of AF:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early studies suggested that exercise-induced AF may be sympathetically driven [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/41,43\">",
"       41,43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The parasympathetic nervous system may contribute to AF in young patients with no structural heart disease [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Animal studies show that vagal stimulation contributes to the genesis of AF by non-uniform shortening of atrial effective refractory periods, thereby setting up substrate for re-entry. Vagal stimulation can also lead to the emergence of focal triggers in the atrium [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/45-47\">",
"       45-47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pulmonary vein (PV) ectopic foci also appear to be at least partially modulated by autonomic signaling, with sympathetic stimulation with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       isoproterenol",
"      </a>",
"      being frequently utilized to &ldquo;bring out&rdquo; these triggers in patients undergoing ablation for AF [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Clinical studies using heart rate variability analysis in patients with focal AF suggest that fluctuation in autonomic tone may be a major determinant of AF in patients with focal ectopy originating from the pulmonary veins [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/49\">",
"       49",
"      </a>",
"      ]. Related studies have also demonstrated a change in heart rate variability after pulmonary vein ablation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/50\">",
"       50",
"      </a>",
"      ], further suggesting that PV triggers may be at least partially modulated by autonomic activity. Bettoni, et al also showed that the occurrence of paroxysmal AF greatly depends on variations of the autonomic tone, with a primary increase in adrenergic tone followed by an abrupt shift toward vagal predominance [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      It is also well known that Bezold-Jarisch-like &lsquo;vagal&rsquo; reflexes can be elicited during radiofrequency ablation and occur in and around the PVs. It has been suggested that elimination of these vagal reflexes during ablation may improve efficacy of AF ablation procedures [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/52\">",
"       52",
"      </a>",
"      ].",
"      <strong>",
"      </strong>",
"     </li>",
"     <li>",
"      Vagal responsiveness also appears to decrease following ablation in the left atrium",
"      <sup>",
"      </sup>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/53\">",
"       53",
"      </a>",
"      ]. In some series, adding ganglionated plexi (GP) ablation to PV isolation appears to increase ablation success for AF [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Recent data suggest that areas in the atrium demonstrating complex fractionated atrial electrograms (CFAE) may represent a suitable target site for ablation; ablation at these sites appears to increase the efficacy of PV isolation procedures",
"      <sup>",
"      </sup>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]. One possible explanation for this improvement in ablation success is that several CFAE sites anatomically overlie fat pads containing GPs [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/13,56\">",
"       13,56",
"      </a>",
"      ]. As indicated above, autonomic denervation performed by GP ablation is thought to improve efficacy of AF ablation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link\">",
"       \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link&amp;anchor=H52#H52\">",
"       \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\", section on 'Complex fractionated atrial electrograms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anatomic studies of the autonomic innervation of the atria also indicate that the PVs and posterior left atrium (PLA) have a unique autonomic profile with a rich innervation from sympathetic and parasympathetic nerves [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/41,57-61\">",
"       41,57-61",
"      </a>",
"      ]. The autonomic nervous system may also be playing a role in the genesis of AF in diseased hearts [",
"      <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/41,62,63\">",
"       41,62,63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recent studies suggest that the parasympathetic and sympathetic nervous system may also be playing a role in creation of AF substrate in the setting of congestive heart failure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13236367\">",
"    <span class=\"h3\">",
"     Role of fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of AF invokes atrial remodeling processes that involve electrophysiological and structural alterations that serve to maintain, promote, and propagate AF. In addition to electrophysiological alterations, such as shortening of the atrial action potential, increased dispersion of refractoriness, and conduction velocity shortening, morphological changes consist of fibrosis, hypertrophy, necrotic and apoptotic cell loss, and dilation.",
"    <sup>",
"    </sup>",
"   </p>",
"   <p>",
"    Of these, fibrosis is considered especially important in the creation of AF substrate, especially in the setting of chronic atrial dilatation caused by heart failure. A canine model of heart failure has demonstrated a progressive increase in AF inducibility with increasing fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/64\">",
"     64",
"    </a>",
"    ]. An increase in conduction heterogeneity noted in this model is thought to play a major role in the creation of re-entrant circuits in the dilated atria. Patients with AF also display increased atrial fibrous tissue content, along with increased expression of collagen I and III [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/65\">",
"     65",
"    </a>",
"    ], as well as up-regulation of MMP-2 protein, and down-regulation of the tissue inhibitor of metalloproteinase, TIMP-1 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/65\">",
"     65",
"    </a>",
"    ]. Expression of the active form of MMP-9 and of monocyte chemoattractant protein-1, an inflammatory mediator, is increased in AF patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/66\">",
"     66",
"    </a>",
"    ]. The left atrial free wall around the pulmonary vein area presents particularly strong interstitial fibrotic changes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/67-69\">",
"     67-69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the underlying molecular mechanisms that lead to the development of atrial fibrosis are complex, recent work suggests that the TGF-&beta; pathway may be an important contributor to the development of fibrosis (especially in the setting of increasing atrial",
"    <span class=\"nowrap\">",
"     stretch/dilatation",
"    </span>",
"    resulting from CHF) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/70-72\">",
"     70-72",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8804404\">",
"    <span class=\"h3\">",
"     Reentrant mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maps of AF in animals and humans suggest that this arrhythmia is caused by multiple wandering wavelets (",
"    <a class=\"graphic graphic_figure graphicRef59310 \" href=\"UTD.htm?31/58/32677\">",
"     figure 4",
"    </a>",
"    ), and these may be due to heterogeneity of atrial refractoriness and conduction. In addition, the response of atrial activity to adenosine infusion suggests a reentrant rather than a focal mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/73\">",
"     73",
"    </a>",
"    ]. Adenosine increases the inward potassium rectifier current, which shortens refractory periods and would accelerate reentrant circuits. In contrast, this effect would slow an automatic or triggered focus. In a series of 33 patients with AF undergoing electrophysiology study, adenosine increased the dominant frequencies, supporting reentrant rather than focal sources for the perpetuation of AF.",
"   </p>",
"   <p>",
"    It has been suggested that at least four to six independent wavelets are required to maintain AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/74\">",
"     74",
"    </a>",
"    ]. These wavelets rarely reenter themselves but can re-excite portions of the myocardium recently activated by another wavefront, a process called random reentry [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/2,75-77\">",
"     2,75-77",
"    </a>",
"    ]. As a result, there are multiple wavefronts of activation that may collide with each other, extinguishing themselves or creating new wavelets and wavefronts, thereby perpetuating the arrhythmia (",
"    <a class=\"graphic graphic_figure graphicRef73931 \" href=\"UTD.htm?30/8/30853\">",
"     figure 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The reentrant circuits are therefore unstable; some disappear, while others reform. These circuits have variable, but short cycle lengths, resulting in multiple circuits to which atrial tissue cannot respond in a 1:1 fashion. As a result, functional block, slow conduction, and multiple wave fronts develop [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with AF may have increased dispersion of refractoriness. This correlates with enhanced inducibility of AF and spontaneous episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/78\">",
"     78",
"    </a>",
"    ] likely related to unstable reentry circuits. Some patients have site-specific dispersion of atrial refractoriness and intraatrial conduction delays resulting from nonuniform atrial anisotropy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/79\">",
"     79",
"    </a>",
"    ]. This appears to be a common property of normal atrial tissue, but there are further conduction delays to and within area surrounding the AV node in patients with induced AF, suggesting an important role for the low right atrium in the genesis of AF.",
"   </p>",
"   <p>",
"    Abnormalities in restitution as well as the spatial distribution of such abnormalities can be related to the persistence of AF. In one study, monophasic action potential recordings were evaluated in patients with AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/80\">",
"     80",
"    </a>",
"    ]. The action potential duration was plotted as a function of the preceding diastolic interval, and the slope of the action potential duration vs the diastolic interval (the restitution curve) was determined. If the slope were greater than one, oscillations occurred that may cause localized conduction delay or block resulting in a wave break giving rise to atrial fibrillation.",
"   </p>",
"   <p>",
"    These different patterns of conduction are reflected in the morphology of electrograms recorded with mapping during induced AF. Single potentials were indicative of rapid uniform conduction, short double potentials indicated collision, long double potentials were indicative of conduction block, while fragmented potentials were markers for pivoting points or slow conduction (",
"    <a class=\"graphic graphic_figure graphicRef52152 \" href=\"UTD.htm?42/45/43737\">",
"     figure 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/81,82\">",
"     81,82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sites of fragmented potentials or complex fractionated atrial electrograms are potential targets for radiofrequency ablation to terminate AF as they may represent critical areas from which AF originates and perpetuates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This phenomenon has been termed microreentry to distinguish it from classic reentry in which the same reentrant pathway is repetitively traversed. The impulse may circulate around a central line of functional block, so-called leading circle reentry; this type of reentry tends not to be stable but rather to drift through the atria until it is extinguished. The perpetuation of AF may also depend importantly upon macroreentry around natural orifices and structures in the atrium, which provides a rationale and anatomic landmarks for ablative treatment. The collision of wavefronts cancels many atrial depolarizations that might otherwise reach the AV node, resulting in a slower heart rate than might otherwise have occurred (",
"    <a class=\"graphic graphic_figure graphicRef57781 graphicRef58689 \" href=\"UTD.htm?28/62/29669\">",
"     figure 7A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although multiple wandering wavelets probably account for the majority of AF, one study reported nine patients in whom a single, rapidly firing focus was identified with electrophysiologic mapping [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/83\">",
"     83",
"    </a>",
"    ]. Organized and rapid atrial activity with a centrifugal and consistent pattern of atrial activation resulted from this focus, but it fired irregularly with striking and abrupt changes in atrial cycle lengths. In most of the patients, the focus was near the ostia of great vessels and was amenable to radiofrequency ablation (",
"    <a class=\"graphic graphic_figure graphicRef55997 \" href=\"UTD.htm?23/50/24352\">",
"     figure 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef66498 \" href=\"UTD.htm?34/60/35777\">",
"     figure 9",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Small reentrant sources, called rotors, may drive or maintain AF in some cases. These rotors result in a hierarchical distribution of frequencies throughout the atria that may be identified with spectral analysis of intracardiac recordings. Ablation of such sites has terminated paroxysmal AF, suggesting that they play an important role [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/84\">",
"     84",
"    </a>",
"    ]. These sites are often localized near the pulmonary vein orifices in patients with paroxysmal AF, and are more often localized to the left or right atria in patients with chronic AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The fibrillating atrium cannot be captured by electrophysiologic pacing when the atrial electrograms are disorganized. This observation supports the presence of microreentry, since there is no excitable gap (or it is very small) to permit capture. However, when type I (",
"    <a class=\"graphic graphic_figure graphicRef66498 \" href=\"UTD.htm?34/60/35777\">",
"     figure 9",
"    </a>",
"    ) AF (which has organized atrial electrograms) is induced by rapid atrial pacing, the fibrillating atrium can be captured with rapid atrial pacing, suggesting the presence of an excitable gap [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8804432\">",
"    <span class=\"h1\">",
"     ROLE OF THE ATRIOVENTRICULAR NODE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The atrioventricular (AV) node regulates the number of atrial impulses that reach the ventricle. The ventricular rate in AF is typically irregularly irregular, with a ventricular rate that may be slow, moderate, or rapid depending on the capacity of the AV node to conduct impulses. The rate of AV nodal conduction is dependent upon multiple factors, including electrical properties of the node and the influence of the autonomic nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/86\">",
"     86",
"    </a>",
"    ]. In addition, the use drugs such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    , calcium channel blockers, or beta blockers may influence AV nodal function. There also may be a circadian rhythm for both AV nodal refractoriness and concealed conduction, accounting for the circadian variation in ventricular response rate [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    AV nodal tissue consists of so-called \"slow response\" fibers, which depend on a mixed",
"    <span class=\"nowrap\">",
"     calcium/sodium",
"    </span>",
"    current. This current is often called the inward calcium current, since in a normal physiologic environment, the ions are almost exclusively calcium. The mixed current uses a kinetically slow channel and is responsible for phase 0 depolarization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=see_link\">",
"     \"Myocardial action potential and action of antiarrhythmic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These characteristics lead to properties that are quite different from \"fast-response\" tissue in the atria, which as noted above, depend on an inward sodium current that uses a kinetically fast channel for phase 0 depolarization [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/3,88\">",
"     3,88",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Partial and complete reactivation returns only 100 msec or more after return to the diastolic potential (versus 10 to 50 msec in the atria)",
"     </li>",
"     <li>",
"      The refractory period changes little as a function of rate.",
"     </li>",
"     <li>",
"      Conduction velocity is relatively slow, ranging from 0.01 to 0.1",
"      <span class=\"nowrap\">",
"       m/sec.",
"      </span>",
"     </li>",
"     <li>",
"      Unlike tissue generating a fast action potential that has an all-or-none response (ie, the velocity of impulse conduction is similar at all stimulation rates until block occurs), tissue that generates a slow action potential exhibits a graded or decremental response, in which the velocity of impulse conduction slows as the stimulation rate increases.",
"     </li>",
"     <li>",
"      As noted above, the ventricular rate usually ranges 90 and 170",
"      <span class=\"nowrap\">",
"       beats/min.",
"      </span>",
"      Ventricular rates below 60",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      are seen with atrioventricular (AV) nodal disease, drugs that affect conduction, and high vagal tone as can occur in a well-conditioned athlete. Ventricular rates above 200",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      suggest catecholamine excess, parasympathetic withdrawal, or the existence of an accessory bypass tract as occurs in the preexcitation syndrome. The QRS complexes are widened in the last setting and must be distinguished from a rate-related or underlying bundle branch block.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the classical view, the AV node is bombarded by impulses from the fibrillating atria. Some impulses traverse the AV node and reach the specialized infranodal conduction system and then the ventricles. However, most atrial impulses penetrate the AV node from varying distances and then are extinguished when they encounter the refractoriness of an earlier wavefront; this phenomenon of concealed conduction in turn creates a refractory wave that affects succeeding impulses. The failure of the refractory period to shorten with increasing rate (as occurs in the atria) further decreases the likelihood of an impulse traversing the AV node.",
"   </p>",
"   <p>",
"    Anatomically distinct AV nodal inputs, called the slow and fast pathways, are involved in the ventricular response to atrial fibrillation. The importance of these pathways has been demonstrated in radiofrequency-ablation studies in which ablation reduced the number of beats that successfully reached the infranodal conduction system and the ventricles [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/89-92\">",
"     89-92",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24793?source=see_link\">",
"     \"Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to its intrinsic properties, the AV node is richly supplied and affected by both components of the autonomic nervous system. AV conduction is enhanced and refractoriness reduced by the sympathetic fibers, and conduction reduced and refractoriness prolonged by the parasympathetic fibers.",
"   </p>",
"   <p>",
"    The net effect of the electrophysiologic properties of the AV node is that the rate of conduction into the specialized infranodal conduction system is (fortunately) much slower than the rate of the fibrillating atria. In some cases, the high degree of refractoriness in the AV node with AF results in high-grade or third-degree block. In this setting, the pacemaker that controls the ventricles is below the AV node. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=see_link&amp;anchor=H7983933#H7983933\">",
"     \"The electrocardiogram in atrial fibrillation\", section on 'Effect of high degrees of AV nodal block and exit block on ventricular response'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with the preexcitation syndrome, the AV node is bypassed by \"fast-response\" tracts, which activate and reactivate much faster than the AV node and are therefore capable of rapid conduction. The development of AF in such a patient can result in very rapid transmission of atrial impulses to the ventricles [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/92\">",
"     92",
"    </a>",
"    ] and can rarely cause ventricular fibrillation (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=see_link&amp;anchor=H184127792#H184127792\">",
"     \"The electrocardiogram in atrial fibrillation\", section on 'AF with an AV bypass tract'",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/10\">",
"     10",
"    </a>",
"    ]. It is also important to recognize that the presence of an accessory pathway can increase the propensity for development of AF. In patients with AF who have Wolff-Parkinson-White (WPW) syndrome, catheter ablation of the accessory pathway is indicated to lower the sudden death risk but also to decrease the probability of recurrent AF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H952331\">",
"    <span class=\"h2\">",
"     Unexpected ventricular rates",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ventricular response to AF characteristically is irregularly irregular although it may appear regular in the presence of complete AV block. The usual ventricular rate in AF is between 90 and 170 beats per minute in the absence of AV-node disease, drugs that affect conduction, or enhanced vagal inputs. Ventricular rates that are clearly outside this range suggest some concurrent problem:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A ventricular rate below 60 beats per minute, in the absence of AV nodal blocking agents, suggests AV nodal disease that may be associated with the sick sinus syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22008?source=see_link\">",
"       \"Manifestations and causes of the sick sinus syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A ventricular rate above 170 beats per minute suggests thyrotoxicosis, catecholamine excess, parasympathetic withdrawal, or the existence of an accessory bypass tract in the preexcitation syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=see_link\">",
"       \"Epidemiology of and risk factors for atrial fibrillation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186292675\">",
"    <span class=\"h1\">",
"     SPECIFIC CLINICAL SITUATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186292723\">",
"    <span class=\"h2\">",
"     After cardiac surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;AF occurs frequently (approximately one of four patients) after cardiac surgery. Nonuniform atrial conduction is greatest on days two and three in this setting, and the longest atrial conduction time is greatest on day three after open heart surgery; these abnormalities coincide with the time of greatest risk for AF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/93\">",
"     93",
"    </a>",
"    ]. The degree of atrial inflammation after surgery in dogs was associated with a proportional increase in the inhomogeneity of atrial conduction and in the duration of AF; antiinflammatory therapy decreased the inhomogeneity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/62/12266/abstract/94\">",
"     94",
"    </a>",
"    ]. Nevertheless, the mechanism of AF in the postoperative period is likely multifactorial. It is important to note that in most of the patients, especially those without a prior history of AF, that the AF is self limited, and antiarrhythmic drug therapy can usually be stopped two to three months following surgery when the inflammation has subsided. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28602?source=see_link\">",
"     \"Atrial fibrillation and flutter after cardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186292766\">",
"    <span class=\"h2\">",
"     Hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is well established that hyperthyroidism can increase susceptibility to development of AF. As a consequence, all patients with new onset AF should have some measure of thyroid function tested. Successful treatment of the hyperthyroidism often results in elimination of the AF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11424260\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The precise mechanisms by which age and other risk factors such as hypertension, coronary artery or valvular heart disease, or heart failure increase the propensity for development of atrial fibrillation (AF) are poorly understood (",
"      <a class=\"graphic graphic_figure graphicRef63675 \" href=\"UTD.htm?31/9/31890\">",
"       figure 1",
"      </a>",
"      ). These conditions may affect the triggers of or the substrate for the maintenance of AF. (See",
"      <a class=\"local\" href=\"#H8807144\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      These mechanisms are complex and involve a dynamic interplay between the triggers and substrate abnormalities. It is likely that short-lived episodes are due to specific triggers, including autonomic perturbations, focal discharges, specific reentry circuits in the pulmonary veins (PV), and effects of stretch, whereas inflammation, dilatation, fibrosis, repolarization abnormalities, and conduction disturbances allow for perpetuation of episodes of AF. (See",
"      <a class=\"local\" href=\"#H11423999\">",
"       'Mechanisms of atrial fibrillation: triggers and substrates'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AF is most often initiated (triggered) by rapid firing from the PV. (See",
"      <a class=\"local\" href=\"#H186294961\">",
"       'Triggers of AF'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Paroxysmal AF commonly precedes chronic AF. This suggests that, in addition to other predisposing factors, AF may play a role in its own natural history. (See",
"      <a class=\"local\" href=\"#H186295411\">",
"       'Electrical remodeling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The autonomic nervous system likely influences the initiation and perpetuation of AF. (See",
"      <a class=\"local\" href=\"#H8804397\">",
"       'Role of the autonomic nervous system'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/1\">",
"      Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011; 91:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/2\">",
"      Allessie MA, Konings K, Kirchhof CJ, Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996; 77:10A.",
"     </a>",
"    </li>",
"    <li>",
"     Arnsdorf, MF. Electrophysiology and biophysics of cardiac excitation. In: Current Concepts of Cardiovascular Physiology, 1st ed, Garfein, O (Eds), Academic Press, Orlando 1990. p.465.",
"    </li>",
"    <li>",
"     Fozzard, HA, Arnsdorf, MF. Cardiac electrophysiology. In: The Heart and Cardiovascular System, Fozzard, HA, Haber, E, Jennings, RB, Katz, AM, Morgan, HE (Eds), Raven Press, New York 1991. p.63.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/5\">",
"      Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/6\">",
"      SCHERF D. Studies on auricular tachycardia caused by aconitine administration. Proc Soc Exp Biol Med 1947; 64:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/7\">",
"      Kalifa J, Jalife J, Zaitsev AV, et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 2003; 108:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/8\">",
"      Thijssen VL, Ausma J, Liu GS, et al. Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol 2000; 9:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/9\">",
"      Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92:1954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/10\">",
"      Klein GJ, Bashore TM, Sellers TD, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979; 301:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/11\">",
"      Elvan A, Huang XD, Pressler ML, Zipes DP. Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs. Circulation 1997; 96:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/12\">",
"      van der Velden HM, Ausma J, Rook MB, et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000; 46:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/13\">",
"      Aim&eacute;-Semp&eacute; C, Folliguet T, R&uuml;cker-Martin C, et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 1999; 34:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/14\">",
"      Elvan A, Wylie K, Zipes DP. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. Circulation 1996; 94:2953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/15\">",
"      Daoud EG, Bogun F, Goyal R, et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996; 94:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/16\">",
"      Tieleman RG, Van Gelder IC, Crijns HJ, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998; 31:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/17\">",
"      Franz MR, Karasik PL, Li C, et al. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997; 30:1785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/18\">",
"      Pandozi C, Bianconi L, Villani M, et al. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation 1998; 98:2860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/19\">",
"      Narayan SM, Krummen DE, Shivkumar K, et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012; 60:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/20\">",
"      Allessie MA. Atrial fibrillation-induced electrical remodeling in humans: what is the next step? Cardiovasc Res 1999; 44:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/21\">",
"      Wijffels MC, Kirchhof CJ, Dorland R, et al. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997; 96:3710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/22\">",
"      Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998; 98:2202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/23\">",
"      Raitt MH, Kusumoto W, Giraud G, McAnulty JH. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/24\">",
"      Brundel BJ, Van Gelder IC, Henning RH, et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 2001; 103:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/25\">",
"      Tieleman RG, De Langen C, Van Gelder IC, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997; 95:1945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/26\">",
"      Daoud EG, Knight BP, Weiss R, et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997; 96:1542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/27\">",
"      Tse HF, Lau CP, Wang Q, et al. Effect of diltiazem on the recurrence rate of paroxysmal atrial fibrillation. Am J Cardiol 2001; 88:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/28\">",
"      Tieleman RG, Blaauw Y, Van Gelder IC, et al. Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation 1999; 100:1836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/29\">",
"      Sticherling C, Oral H, Horrocks J, et al. Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness. Circulation 2000; 102:2503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/30\">",
"      Vest JA, Wehrens XH, Reiken SR, et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005; 111:2025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/31\">",
"      Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008; 1:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/32\">",
"      Nakashima H, Kumagai K, Urata H, et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101:2612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/33\">",
"      Goette A, Arndt M, R&ouml;cken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000; 101:2678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/34\">",
"      Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/35\">",
"      Vermes E, Tardif JC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003; 107:2926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/36\">",
"      Jayachandran JV, Zipes DP, Weksler J, Olgin JE. Role of the Na(+)/H(+) exchanger in short-term atrial electrophysiological remodeling. Circulation 2000; 101:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/37\">",
"      Sheng X, Scherlag BJ, Yu L, et al. Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation. J Am Coll Cardiol 2011; 57:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/38\">",
"      Scherlag BJ, Nakagawa H, Jackman WM, et al. Non-pharmacological, non-ablative approaches for the treatment of atrial fibrillation: experimental evidence and potential clinical implications. J Cardiovasc Transl Res 2011; 4:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/39\">",
"      Lu Z, Scherlag BJ, Lin J, et al. Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi. Cardiovasc Res 2009; 84:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/40\">",
"      Chou CC, Chen PS. New concepts in atrial fibrillation: neural mechanisms and calcium dynamics. Cardiol Clin 2009; 27:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/41\">",
"      Shen MJ, Choi EK, Tan AY, et al. Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol 2012; 9:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/42\">",
"      Yamaguchi Y, Kumagai K, Nakashima H, Saku K. Long-term effects of box isolation on sympathovagal balance in atrial fibrillation. Circ J 2010; 74:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/43\">",
"      Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol 1996; 7:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/44\">",
"      Chen PS, Tan AY. Autonomic nerve activity and atrial fibrillation. Heart Rhythm 2007; 4:S61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/45\">",
"      Nemirovsky D, Hutter R, Gomes JA. The electrical substrate of vagal atrial fibrillation as assessed by the signal-averaged electrocardiogram of the P wave. Pacing Clin Electrophysiol 2008; 31:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/46\">",
"      Sharifov OF, Fedorov VV, Beloshapko GG, et al. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J Am Coll Cardiol 2004; 43:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/47\">",
"      Hirose M, Carlson MD, Laurita KR. Cellular mechanisms of vagally mediated atrial tachyarrhythmia in isolated arterially perfused canine right atria. J Cardiovasc Electrophysiol 2002; 13:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/48\">",
"      Crawford T, Chugh A, Good E, et al. Clinical value of noninducibility by high-dose isoproterenol versus rapid atrial pacing after catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/49\">",
"      Zimmermann M, Kalusche D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J Cardiovasc Electrophysiol 2001; 12:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/50\">",
"      Hsieh MH, Chiou CW, Wen ZC, et al. Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. Circulation 1999; 100:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/51\">",
"      Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002; 105:2753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/52\">",
"      Pappone C, Santinelli V, Manguso F, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004; 109:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/53\">",
"      Verma A, Saliba WI, Lakkireddy D, et al. Vagal responses induced by endocardial left atrial autonomic ganglion stimulation before and after pulmonary vein antrum isolation for atrial fibrillation. Heart Rhythm 2007; 4:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/54\">",
"      Arruda M, Natale A. Ablation of permanent AF: adjunctive strategies to pulmonary veins isolation: targeting AF NEST in sinus rhythm and CFAE in AF. J Interv Card Electrophysiol 2008; 23:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/55\">",
"      Porter M, Spear W, Akar JG, et al. Prospective study of atrial fibrillation termination during ablation guided by automated detection of fractionated electrograms. J Cardiovasc Electrophysiol 2008; 19:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/56\">",
"      Katritsis D, Giazitzoglou E, Sougiannis D, et al. Complex fractionated atrial electrograms at anatomic sites of ganglionated plexi in atrial fibrillation. Europace 2009; 11:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/57\">",
"      Hou Y, Scherlag BJ, Lin J, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol 2007; 50:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/58\">",
"      Hou Y, Scherlag BJ, Lin J, et al. Interactive atrial neural network: Determining the connections between ganglionated plexi. Heart Rhythm 2007; 4:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/59\">",
"      Arora R, Ulphani JS, Villuendas R, et al. Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium. Am J Physiol Heart Circ Physiol 2008; 294:H134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/60\">",
"      Ulphani JS, Arora R, Cain JH, et al. The ligament of Marshall as a parasympathetic conduit. Am J Physiol Heart Circ Physiol 2007; 293:H1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/61\">",
"      Arora R, Ng J, Ulphani J, et al. Unique autonomic profile of the pulmonary veins and posterior left atrium. J Am Coll Cardiol 2007; 49:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/62\">",
"      Ogawa M, Zhou S, Tan AY, et al. Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure. J Am Coll Cardiol 2007; 50:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/63\">",
"      Ng J, Villuendas R, Cokic I, et al. Autonomic remodeling in the left atrium and pulmonary veins in heart failure: creation of a dynamic substrate for atrial fibrillation. Circ Arrhythm Electrophysiol 2011; 4:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/64\">",
"      Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999; 100:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/65\">",
"      Polyakova V, Miyagawa S, Szalay Z, et al. Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med 2008; 12:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/66\">",
"      Pellman J, Lyon RC, Sheikh F. Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation. J Mol Cell Cardiol 2010; 48:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/67\">",
"      Corradi D, Callegari S, Maestri R, et al. Heme oxygenase-1 expression in the left atrial myocardium of patients with chronic atrial fibrillation related to mitral valve disease: its regional relationship with structural remodeling. Hum Pathol 2008; 39:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/68\">",
"      Corradi D, Callegari S, Benussi S, et al. Myocyte changes and their left atrial distribution in patients with chronic atrial fibrillation related to mitral valve disease. Hum Pathol 2005; 36:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/69\">",
"      Corradi D, Callegari S, Benussi S, et al. Regional left atrial interstitial remodeling in patients with chronic atrial fibrillation undergoing mitral-valve surgery. Virchows Arch 2004; 445:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/70\">",
"      Nakajima H, Nakajima HO, Salcher O, et al. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res 2000; 86:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/71\">",
"      Lamirault G, Gaborit N, Le Meur N, et al. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. J Mol Cell Cardiol 2006; 40:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/72\">",
"      Lee KW, Everett TH 4th, Rahmutula D, et al. Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation 2006; 114:1703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/73\">",
"      Atienza F, Almendral J, Moreno J, et al. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation 2006; 114:2434.",
"     </a>",
"    </li>",
"    <li>",
"     Allessie, MA, Lammers, WJEP, Bonke, FIM, et, al. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Cardiac Arrhythmias, Zipes, DP, Jalife, J (Eds), Grune and Stratton, Orlando 1985. p.265.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/75\">",
"      Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962; 140:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/76\">",
"      Konings KT, Kirchhof CJ, Smeets JR, et al. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994; 89:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/77\">",
"      Kumagai K, Khrestian C, Waldo AL. Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. Circulation 1997; 95:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/78\">",
"      Ramanna H, Hauer RN, Wittkampf FH, et al. Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. Circulation 2000; 101:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/79\">",
"      Papageorgiou P, Monahan K, Boyle NG, et al. Site-dependent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation. Circulation 1996; 94:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/80\">",
"      Kim BS, Kim YH, Hwang GS, et al. Action potential duration restitution kinetics in human atrial fibrillation. J Am Coll Cardiol 2002; 39:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/81\">",
"      Konings KT, Smeets JL, Penn OC, et al. Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. Circulation 1997; 95:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/82\">",
"      Holm M, Johansson R, Brandt J, et al. Epicardial right atrial free wall mapping in chronic atrial fibrillation. Documentation of repetitive activation with a focal spread--a hitherto unrecognised phenomenon in man. Eur Heart J 1997; 18:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/83\">",
"      Ja&iuml;s P, Ha&iuml;ssaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/84\">",
"      Sanders P, Berenfeld O, Hocini M, et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 2005; 112:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/85\">",
"      Daoud EG, Pariseau B, Niebauer M, et al. Response of type I atrial fibrillation to atrial pacing in humans. Circulation 1996; 94:1036.",
"     </a>",
"    </li>",
"    <li>",
"     Janse, MJ. Propagation of atrial impulses through the atrioventricular node. In: Atrial Arrhythmias: Current Concepts and Management, Touboul, P, Waldo, AL (Eds), Mosby, St. Louis 1990. p.141.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/87\">",
"      Hayano J, Sakata S, Okada A, et al. Circadian rhythms of atrioventricular conduction properties in chronic atrial fibrillation with and without heart failure. J Am Coll Cardiol 1998; 31:158.",
"     </a>",
"    </li>",
"    <li>",
"     Fozzard HA, Arnsdorf MF. Cardiac electrophysiology. In: The Heart and Cardiovascular System, Fozzard HA, Haber E, Jennings RB, et al (Eds), Raven Press, New York 1991. p.63.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/89\">",
"      Fleck RP, Chen PS, Boyce K, et al. Radiofrequency modification of atrioventricular conduction by selective ablation of the low posterior septal right atrium in a patient with atrial fibrillation and a rapid ventricular response. Pacing Clin Electrophysiol 1993; 16:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/90\">",
"      Williamson BD, Man KC, Daoud E, et al. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994; 331:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/91\">",
"      Della Bella P, Carbucicchio C, Tondo C, Riva S. Modulation of atrioventricular conduction by ablation of the \"slow\" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter. J Am Coll Cardiol 1995; 25:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/92\">",
"      Kreiner G, Heinz G, Siostrzonek P, G&ouml;ssinger HD. Effect of slow pathway ablation on ventricular rate during atrial fibrillation. Dependence on electrophysiological properties of the fast pathway. Circulation 1996; 93:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/93\">",
"      Tsikouris JP, Kluger J, Song J, White CM. Changes in P-wave dispersion and P-wave duration after open heart surgery are associated with the peak incidence of atrial fibrillation. Heart Lung 2001; 30:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/62/12266/abstract/94\">",
"      Ishii Y, Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005; 111:2881.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16402 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-3BFBD2B80D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12266=[""].join("\n");
var outline_f11_62_12266=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11424260\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8807144\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186292585\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186294596\">",
"      BASIC ATRIAL ELECTROPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186292593\">",
"      CLINICAL FACTORS ASSOCIATED WITH AF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11423999\">",
"      MECHANISMS OF ATRIAL FIBRILLATION: TRIGGERS AND SUBSTRATES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186294961\">",
"      Triggers of AF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8804369\">",
"      - Role of atrial premature beats and other arrhythmia triggers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H186294723\">",
"      - Role of atrial flutter and SVT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186294983\">",
"      Maintenance of AF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8621795\">",
"      - Atrial remodeling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H186295411\">",
"      - Electrical remodeling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8804397\">",
"      - Role of the autonomic nervous system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13236367\">",
"      - Role of fibrosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8804404\">",
"      - Reentrant mechanism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8804432\">",
"      ROLE OF THE ATRIOVENTRICULAR NODE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H952331\">",
"      Unexpected ventricular rates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186292675\">",
"      SPECIFIC CLINICAL SITUATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186292723\">",
"      After cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186292766\">",
"      Hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11424260\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/16402\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/16402|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/9/31890\" title=\"figure 1\">",
"      AF mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/50/21280\" title=\"figure 2\">",
"      AF remodeling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/2/25645\" title=\"figure 3\">",
"      SAECG predicts atrial fibrillation post CABG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/58/32677\" title=\"figure 4\">",
"      Atrial activation in AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/8/30853\" title=\"figure 5\">",
"      Reentry in AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/45/43737\" title=\"figure 6\">",
"      Atrial electrograms in AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/53/11089\" title=\"figure 7A\">",
"      Normal impulse conduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/56/3968\" title=\"figure 7B\">",
"      Electrical activity in AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/50/24352\" title=\"figure 8\">",
"      Noncontact map focal AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/60/35777\" title=\"figure 9\">",
"      AF activation patterns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36825?source=related_link\">",
"      Actions of angiotensin II on the heart",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26088?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28602?source=related_link\">",
"      Atrial fibrillation and flutter after cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24793?source=related_link\">",
"      Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=related_link\">",
"      Epidemiology of and risk factors for atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22008?source=related_link\">",
"      Manifestations and causes of the sick sinus syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=related_link\">",
"      Myocardial action potential and action of antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=related_link\">",
"      Overview of atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=related_link\">",
"      Radiofrequency catheter ablation to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22426?source=related_link\">",
"      Restoration of sinus rhythm in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/45/37591?source=related_link\">",
"      Surgical approaches to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=related_link\">",
"      The electrocardiogram in atrial fibrillation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_62_12267="MMRC dyspnea scale";
var content_f11_62_12267=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F86426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F86426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Modified Medical Research Council (MMRC) dyspnea scale",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description of breathlessness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td>",
"        I only get breathless with strenuous exercise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        I get short of breath when hurrying on level ground or walking up a slight hill",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td>",
"        On level ground, I walk slower than people of the same age because of breathlessness, or have to stop for breath when walking at my own pace",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td>",
"        I stop for breath after walking about 100 yards or after a few minutes on level ground",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td>",
"        I am too breathless to leave the house or I am breathless when dressing",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Fletcher CM, Elmes PC, Fairbairn MB, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. British Medical Journal 1959; 2:257.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12267=[""].join("\n");
var outline_f11_62_12267=null;
var title_f11_62_12268="Constipation assessment scale";
var content_f11_62_12268=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F62148&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F62148&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Constipation assessment scale",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"4\" rowspan=\"1\">",
"        Directions:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\" rowspan=\"1\">",
"        Circle the appropriate number to",
"indicate whether, during the past three days, you have had NO PROBLEM,",
"SOME PROBLEM, or a SEVERE PROBLEM with each of the items listed below.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Item",
"       </td>",
"       <td class=\"subtitle1\">",
"        No problem",
"       </td>",
"       <td class=\"subtitle1\">",
"        Some problem",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severe problem",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Abdominal distention or bloating",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Change in amount of gas passed rectally",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Less frequent bowel movements",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Oozing liquid stool",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Rectal fullness or pressure",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Rectal pain with bowel movement",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Small stool size",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Urge but inability to pass stool",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: McMillan, SC, Williams, F. Validity and reliability of the constipation assessment scale. Cancer Nursing 1989; 12:183; and McMillan, SC, Levy, D. Reassessment of the validity and reliability of the CAS (and unpublished study).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12268=[""].join("\n");
var outline_f11_62_12268=null;
var title_f11_62_12269="Adjusting Rx 0 to 4 yrs";
var content_f11_62_12269=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78322&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78322&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Assessing asthma control and adjusting therapy in children 0-4 years of age",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"2\">",
"        Components of control",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Classification of asthma control (0-4 years of age)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Well-controlled",
"       </td>",
"       <td class=\"subtitle2\">",
"        Not-well controlled",
"       </td>",
"       <td class=\"subtitle2\">",
"        Very poorly controlled",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Impairment",
"       </td>",
"       <td>",
"        Symptoms",
"       </td>",
"       <td>",
"        &le;2 days/week",
"       </td>",
"       <td>",
"        &gt;2 days/week",
"       </td>",
"       <td>",
"        Throughout the day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nighttime awakenings",
"       </td>",
"       <td>",
"        &le;1x/month",
"       </td>",
"       <td>",
"        &gt;1x/month",
"       </td>",
"       <td>",
"        &gt;1x/week",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interference with normal activity",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Some limitation",
"       </td>",
"       <td>",
"        Extremely limited",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Short-acting beta",
"        <sub>",
"         2",
"        </sub>",
"        -agonist use for symptom control (not prevention of EIB)",
"       </td>",
"       <td>",
"        &le;2 days/week",
"       </td>",
"       <td>",
"        &gt;2 days/week",
"       </td>",
"       <td>",
"        Several times per day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Risk",
"       </td>",
"       <td>",
"        <strong>",
"         Exacerbations requiring oral systemic corticosteroids",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         0-1/year",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         2-3/year",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         &gt;3/year",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment-related adverse effects",
"       </td>",
"       <td colspan=\"3\">",
"        Medication side effects can vary in intensity from none to very troublesome and worrisome. The level of intensity does not correlate to specific levels of control but should be considered in the overall assessment of risk.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Recommended action for treatment",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Maintain current treatment.",
"        </p>",
"        <p>",
"         &bull; Regular followups every 1-6 months.",
"        </p>",
"        <p>",
"         &bull; Consider step down if well controlled for at least 3 months.",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Step up (1 step) and",
"        </p>",
"        <p>",
"         &bull; Reevaluate in 2-6 weeks.",
"        </p>",
"        <p>",
"         &bull; If no clear benefit in 4-6 weeks, consider alternative diagnoses or adjusting therapy.",
"        </p>",
"        <p>",
"         &bull; For side effects, consider alternative treatment options.",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Consider short course of oral systemic corticosteroids,",
"        </p>",
"        <p>",
"         &bull; Step up (1-2 steps), and",
"        </p>",
"        <p>",
"         &bull; Reevaluate in 2 weeks.",
"        </p>",
"        <p>",
"         &bull; If no clear benefit in 4-6 weeks, consider alternative diagnoses or adjusting therapy.",
"        </p>",
"        <p>",
"         &bull; For side effects, consider alternative treatment options.",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The stepwise approach is meant to assist, not replace, the clinical decisionmaking required to meet individual patient needs. The level of control is based on the most severe impairment or risk category. Assess impairment domain by caregiver's recall of previous 2-4 weeks. Symptom assessment for longer periods should reflect a global assessment such as inquiring whether the patient's asthma is better or worse since the last visit. At present, there are inadequate data to correspond frequencies of exacerbations with different levels of asthma control. In general, more frequent and intense exacerbations (eg, requiring urgent, unscheduled care, hospitalization, or ICU admission) indicate poorer disease control. For treatment purposes, patients who had &ge;2 exacerbations requiring oral systemic corticosteroids in the past year may be considered the same as patients who have not-well-controlled asthma, even in the absence of impairment levels consistent with not-well-controlled asthma.",
"    <br>",
"     <strong>",
"      Before step up in therapy:",
"     </strong>",
"     <br>",
"      - Review adherence to medication, inhaler technique, and environmental control.",
"      <br>",
"       - If an alternative treatment option was used in a step, discontinue and use the preferred treatment for that step.",
"       <div class=\"footnotes\">",
"        EIB: exercise-induced bronchospasm.",
"       </div>",
"       <div class=\"reference\">",
"        Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12269=[""].join("\n");
var outline_f11_62_12269=null;
var title_f11_62_12270="Pravastatin outcome vs age";
var content_f11_62_12270=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Benefit of lipid lowering with pravastatin is greater in the elderly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 240px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier estimates from the CARE trial of patients with a recent history of myocardial infarction who had \"average\" lipid levels. Pravastatin lowered the incidence of coronary events (cardiac mortality, nonfatal myocardial infarction, coronary artery bypass grafting, and angioplasty) in all age groups but the percentage relative risk reduction attributable to pravastatin was more prominent in the elderly (32 versus 19 percent in younger patients).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Lewis, SJ, Moye, LA, Sacks, FM, et al, for the CARE Investigators. Ann Intern Med 1998; 129:681.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12270=[""].join("\n");
var outline_f11_62_12270=null;
var title_f11_62_12271="Fibroid embolization 2b";
var content_f11_62_12271=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74642&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74642&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fibroid embolization 2b",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 290px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram showing embolic particles being released from the catheter and into the uterine arterial branches supplying the fibroid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_62_12271=[""].join("\n");
var outline_f11_62_12271=null;
